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ABSTRACT 
 
Emerging research suggests that high protein diets may have a role in preventing 
obesity, sarcopenia, diabetes, and optimizing muscle mass and bone health.  Evidence is 
mounting that these benefits may be in part due to the amino acid leucine (leu) and its 
unique ability to stimulate muscle protein synthesis (MPS).  Current dietary protein 
recommendations for protein quantity and quality are defined as the minimum daily 
amount to prevent deficiencies of limiting amino acids and increases in plasma amino 
acids are regarded as ‘excess’ or inefficient use of amino acids due to increased amino 
acid oxidation.  This view does not account for the meal responses of MPS associated 
with intracellular signaling in response to increasing plasma leu.   
The goal of this research was to elucidate the physiological role that leu plays in 
complete meals and to determine if the meal distribution of protein or leu is important for 
optimization of muscle mass.  My hypothesis was that optimum MPS would equate to 
maximum signaling response of the kinase known as mammalian target of rapamycin 
(mTOR) and directly related to post-prandial plasma leu concentration. Ultimately, the 
leu content of individual meals and the number of meal per day with sufficient leu to 
increase MPS will influence muscle mass, lean body mass and long term body 
composition  
In vivo work with purified solutions established that leu has a regulatory role for 
initiating MPS by activating mTOR and there is a clear threshold of leu required to 
increase plasma leu and stimulate MPS.  In order to test the role of leu in complete meals 
we examined the duration and peak activation of MPS and mTOR signaling in response 
to complete test meals containing 10, 20, and 30% of total energy from wheat and whey 
protein (6.8 and 10.9% leu) respectively.  We determined that whey increased plasma leu, 
mTOR signaling, and MPS more than wheat at all protein intakes.  Stimulation of MPS 
after meals last for 3 hours with a peak at 90 minutes, however plasma leu and mTOR 
signaling remained at a plateau for 3 hours before decreasing.  Meal leu content and the 
increases in postprandial plasma leu were closely associated with peak activation of 
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mTOR signaling and MPS but did not determine the duration of protein synthesis which 
demonstrated a refractory response to the constant elevations in plasma leu.     
Experiment 2 examined the potential to use leu to predict the quality of individual 
proteins to stimulate mTOR signaling and MPS. Adult rats were adapted for 2 weeks to a 
meal-feeding protocol with complete diets containing 16% protein but with different leu 
contents using wheat, soy, egg, or whey proteins (6.8, 8.0, 8.8, and 10.9% leu).  Animals 
fed egg and whey significantly increased plasma leu and MPS whereas animals fed wheat 
and soy did not.  The leu content of the meals predicted mTOR signaling and peak MPS 
responses and were closely related to changes in plasma leu.  These findings support the 
hypothesis that there is a meal leu threshold for increasing plasma leu.      
 While experiment 2 provided proof of concept that there is a meal threshold for 
leu stimulation of MPS, the critical outcomes are changes in muscle mass or body 
composition. This study tested the hypothesis that long-term meal-feeding of 
isonitrogenous/isocaloric diets with 16/54/30% of energy from 
protein/carbohydrates/lipids, respectively, using protein sources (wheat, soy, egg, whey) 
with different leu contents could produce body composition and muscle weight outcomes 
in relation to the changes in postprandial MPS and plasma leu observed in the previous 
experiments.  Based on the leu threshold observed in the previous experiment, the diets 
were designed such that animals fed egg and whey proteins would receive sufficient leu 
during each of the three meals to achieve three stimulations of MPS per day as opposed 
to animals fed wheat and soy proteins with lower leu contents that would achieve the leu 
threshold only at the larger dinner meal.  After 11 weeks of meal-feeding, body 
composition, lean body mass, and gastrocnemius muscle weights were positively related 
to the leu content of the diet and reflected the ability of the respective diets to increase 
postprandial plasma leu and MPS.   
Finally, we tested the hypothesis that long-term distribution of protein/leu could 
make a difference in body composition by feeding isocaloric/isonitrogenous meals 
containing whey protein evenly distributed to achieve the leu thresholds at each of 3 
meals (ED-Whey) daily or unevenly distributed over 3 meals (UD-Whey) with only the 
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dinner meal exceeding the leu threshold.  The ED-Whey treatment with evenly 
distributed leu produced multiple stimulations of MPS throughout the day and larger 
gastrocnemius muscle weights compared to the UD-whey that only achieved stimulation 
of MPS at a single meal. While muscle mass was larger in the ED-Whey treatment, total 
lean body mass was not different between groups.  This may have been due to the large 
protein (i.e. nitrogen) content of the dinner meal in the UD-Whey group producing a shift 
in lean body mass deposition to the liver and visceral tissues, which were larger in the 
UD-Whey group.                         
 In summary, the leu content of complete meals is an important regulator of MPS 
and produces different body composition outcomes with long term feeding of diets 
differing in leu contents and leu/protein distribution.  These results cannot be explained 
by limiting amino acids and are not accounted for by current protein quantity and quality 
recommendations.   
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CHAPTER 1: Introduction 
 
Background 
Concerns with current dietary protein guidelines 
 Dietary protein needs are defined as both the amount and quality of protein to 
meet metabolic requirements.  However, current nutrition guidelines for dietary protein 
use the Recommended Dietary Allowance (RDA) which provides only the minimum 
amount of protein to maintain short-term nitrogen balance based largely on data from 
young adults in ideal health and energy balance. Information is increasing that these 
guidelines are not adequate to meet metabolic needs or maintain optimum long-term 
health for adults in environments with sedentary lifestyles and excess dietary energy.  
 Current standards for protein quality use measurements of animal growth (protein 
efficiency ratio or PER), or in humans, nitrogen balance, where both digestibility and the 
suitability of the amino acid pattern of absorbed amino acids, (biological value or BV), 
determines net protein utilization (NPU). The practical difficulties and poor sensitivity of 
the nitrogen balance method has led to the adoption of the PDCAAS approach, i.e. the 
Protein Digestibility-Corrected Amino Acid Score.  
 PDCAAS, which was introduced by Food and Agriculture Organization of the 
World Health Organization (FAO/WHO in 1991 (1), is the current international standard 
for protein quality assessment (2).  PDCAAS is based on the combination of an age-
related amino acid reference pattern that is representative of human requirements plus 
estimates of the digestibility of the protein.  The amount of potentially limiting amino 
acids in the test protein is compared to their respective content in the appropriate 
reference pattern, identifying the single most limiting amino acid which determines the 
amino acid score.  The current consensus is that meeting the minimum requirements for 
lysine, methionine, and tryptophan, considered the most limiting amino acids in poor 
quality proteins, determines the amino acid score and will lead to a plateau of nitrogen 
retention (2).  At the plateau of nitrogen balance, any further increase in plasma amino 
acids would stimulate increased oxidation and elimination of the “excess” amino acids, 
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implying that protein quality above requirements does not matter.  This score is assumed 
to predict the Biological Value (BV) of a protein, or the anticipated ability of the 
absorbed test protein to fulfill human amino acid requirements. The score is then 
corrected for digestibility giving the PDCAAS value, which is assumed to predict NPU.  
This method of measuring protein quality however does not account for any metabolic 
value of amino acids above the minimum reference score. These amino acids are simply 
considered to be in “excess” of needs.  The fact that increasing plasma amino acids 
causes an increase in oxidation does not mean that these amino acids have no 
physiological value or do not participate in important roles in cell metabolism or 
intracellular signaling prior to their oxidation or even after oxidation.  As understanding 
of metabolic actions of amino acids expand, the concept of protein quality also expands 
to incorporate these newly emerging actions of amino acids into a protein quality 
concept.  New research reveals increasingly complex roles for amino acids in regulation 
of body composition, glucose homeostasis, and cell signaling.  More importantly 
increased dietary protein intake may have enhance health and prevent muscle loss in 
aging adult populations. 
 A new concern about dietary recommendations is protein distribution.  Current 
recommendations of protein quantity are daily requirements, assuming that the 
distribution of protein is unimportant so long as the total daily protein goal is met and 
data from de Castro et al. indicates that adults consume nearly 65% of their protein at 
dinner (6).  However, there is mounting evidence however that metabolic responses of 
muscle protein synthesis (MPS) and signaling through the mammalian target of 
rapamycin (mTOR) are regulated on a meal-to-meal basis (3-5).  If true, a logical 
extension is that multiple stimulations of MPS are superior to a single stimulation of MPS 
for optimizing maintenance of muscle mass.  It is unlikely that other meals contain 
sufficient leu to saturate the leu signaling mechanism and stimulate MPS.  Therefore, 
many adults may meet total protein requirements on a per day basis, but not optimize 
individual meal responses of MPS. 
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Dietary protein and muscle mass with aging 
 An important example of the need for an expanded understanding of protein 
quality and amino acid needs is the age-related disease of sarcopenia. Sarcopenia is 
defined as the loss of skeletal muscle mass, strength, and endurance with age.  Whereas 
muscle wasting and cachexia are rapid losses in muscle mass, sarcopenia is a gradual loss 
of muscle mass (~0.5-1% /year) beginning approximately at age 40.  Advanced 
sarcopenia is associated with muscle weakness, frailty, increased likelihood of disability, 
reduced quality of life, and increased falls in the elderly (7).  The number of people age 
65 and older is expected to increase by ~80% in the next 20 years so this presents a large 
scale health concern for our aging population.   
 Sarcopenia is associated with a variety of metabolic and social factors including 
sedentary lifestyle and suboptimal diet.  Many elderly choose to eat less protein due to 
problems with chewing, digestion, expense of high protein foods, and increased satiety.  
These lifestyle changes are compounded by a reduced anabolic response to dietary 
protein intake in the elderly which may be due to decreased intramuscular expression and 
phosphorylation of signaling proteins (i.e. mTOR, p70 S6 kinase (S6K), and eukaryotic 
initiation factors 4E-BP1 and 2B) (8-10).   
Insufficient protein intake in elderly individuals may cause loss of muscle by reducing 
MPS and thus promoting net muscle protein catabolism (10, 11).  Even moderate 
increases in protein intake may help prevent muscle loss and improve anabolic signaling 
in the elderly (12, 13).  Interestingly, Arnal et al. has demonstrated that protein 
distribution and intake at individual meals may be equally important as total daily protein 
intake in the elderly (5).  These data indicate the need to define benefits of high protein 
diets for adults and elderly and the quantity and quality of protein intake needed to 
achieve these benefits.  Furthermore, if protein needs to maintain muscle mass increase 
with aging, understanding and acceptance of this change in metabolic requirements 
requires a clear mechanism with measurable outcomes. 
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Leucine metabolism and metabolic effects 
 A proposed mechanism to explain these phenomena is an age-related shift in 
regulation of MPS from a hormone-driven growth model to a model of amino acid 
signaling driven by the branched-chain amino acid (BCAA) leucine (leu) (3, 14).  Leu is 
unique among amino acids for its regulatory roles in metabolism, including translational 
control of MPS (14, 15) via stimulation of the mTOR signaling pathway.  Research from 
Garlick et al. indicates that the anabolic effects of amino acids can be contributed to leu 
(16).  The metabolic effects of leu are, at least in part, associated with the absence of the 
branched-chain aminotransferase (BCAT) enzyme in liver (17). Absence of BCAT in 
liver results in an increased supply of the three BCAAs available to skeletal muscle. 
Dietary BCAA reach the blood virtually unaltered from their levels in the diet; thus, leu 
reaches peripheral tissues in direct proportion to its dietary intake. 
     
Translational control of muscle protein synthesis by leucine 
Short-term regulation of MPS is achieved at the level of translation, with primary 
emphasis on the assembly of the structural machinery for MPS through initiation (15, 18). 
The basic components for protein synthesis include the large (60S) and small (40S) 
ribosomal subunits, mRNA coding for individual proteins, transfer RNA (tRNA) for 
individual amino acids, and more than a dozen catalytic proteins identified as eukaryotic 
initiation factors (eIFs). These eIFs serve to guide the assembly of the ribosome on the 
mRNA and provide the cell with sensitivity to environmental factors responding to 
changes in diet (such as leu availability) and physical activity.  
Ribosome assembly on mRNA requires activation of the 40S ribosomal subunit 
and preparation of the 5'cap end of the mRNA.  This is facilitated by binding of the 40S 
ribosomal subunit with eIF2, which carries a high energy molecule of GTP, and the 
initiator amino acid methionine (Met-tRNA). This complex of eIF2-GTP-Met-tRNA 
(known as the ternary complex) binds with the 40S subunit to form the 43S pre-initiation 
complex. Formation of the ternary complex is sensitive to cellular energy status and 
intracellular leu concentrations (15, 19).  
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Binding of the 43S pre-initiation complex to an mRNA is believed to be a rate-controlling 
step in translation initiation (15, 19, 20). This binding is facilitated by eIF4F, a three-
subunit complex consisting of (1) eIF4E, a protein that binds to the 5'cap structure of the 
mRNA to be translated; (2) eIF4G, a peptide that serves as a scaffold to connect eIF4E 
and eIF4A with the mRNA and 40S subunit; and (3) eIF4A, a RNA helicase that 
functions to unwind secondary structure in the 5'-untranslated region of the mRNA. The 
function of the eIF4F complex is to recognize, unfold, and guide the mRNA to the 43S 
pre-initiation complex.  
Formation of the eIF4F complex is regulated through the availability of eIF4E for 
binding with eIF4G and the phosphorylation state of eIF4G. Availability of eIF4E for 
eIF4G is controlled by the eIF4E inhibitory binding protein 4E-BP1. Binding of 4E-BP1 
with eIF4E prevents the formation of the eIF4E-eIF4G complex (21). Binding of 4E-BP1 
to eIF4E is determined by the phosphorylation state of the binding protein. 
Phosphorylation of 4E-BP1 by the protein kinase mTOR reduces the affinity of 4E-BP1 
for eIF4E, allowing eIF4E to bind with eIF4G and form the active eIF4F complex. 
Activity of mTOR is sensitive to leu concentrations and stimulation through the PI3-
kinase signal cascade. 
 Another downstream target of mTOR is the 70-kD ribosomal protein S6 kinase 
(S6K). S6K is activated by phosphorylation from mTOR and the active S6K in turn 
activates the ribosomal protein S6 (rpS6) allowing it to bind to the 40S subunit (15, 19). 
Activation of rpS6 results in preferential translation of mRNAs that encode components 
of the MPS mechanism, including the ribosomal proteins eIF4G, eukaryotic elongation 
factors (eEF1 and eEF2), and poly(A) binding protein. All of these proteins are involved 
in translation of mRNA to protein.  Activation of S6K therefore increases the cell's 
capacity for MPS. Together, the effects of leu concentration through mTOR activity on 
eIF4E and S6K influence both the rate and capacity of translation in skeletal muscle. 
Inhibiting mTOR prevents phosphorylation and activation of S6K.  
 Furthermore, though important, mTOR alone does not fully account for leu 
stimulation of MPS. For instance, co-administration of leu with the mTOR inhibitor 
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rapamycin only partially inhibited the leu-induced increase in MPS (22).  Interestingly, 
leu has been shown to increase MPS via an mTOR independent mechanism that increases 
eIF4G phosphorylation (4, 23).  Thus, leu concentration is important for both availability 
of eIF4E and activation of eIF4G. 
 
In vivo effects of leucine on protein synthesis and mTOR signaling   
 Leucine effects on protein synthesis have been shown to be age-dependent with 
stimulation of MPS requiring greater amounts of leu with increasing age (24). Elderly 
require a high proportion of leu in an essential amino acid mixture for stimulation of 
MPS (25). The reduced anabolic response to leu and essential amino acids is associated 
with a decrease in total mTOR and S6K content and reduced activation of mTOR (10).  
MPS can be restored in old rats if leu concentrations are raised to supra-physiological 
concentrations (24). In humans, Katsanos et al. (25) found that MPS can be increased in 
the elderly using a small dose of essential amino acids (6.7g) containing a high 
proportion (2.8g) of leu.  The same dose of EAA failed to stimulate MPS when the leu 
content was reduced to 1.7g. These results are in accordance with the research by Arnal 
et al. (5) that showed the anabolic response of whole body protein turnover to a meal 
could be normalized in the elderly using a protein-pulse feeding pattern providing a large 
amount of amino acids at a meal.  Furthermore, Garlick et al. demonstrated leu alone will 
stimulate MPS to the same extent as a solution containing all the amino acids (16).  It is 
likely that the progressive loss of muscle mass during aging may be in part attributed to 
consumption of meals insufficient in leu to initiate MPS in skeletal muscle multiple times 
per day. 
 
Significance 
 These data suggest that there is a threshold of leu that must be achieved within the 
protein intake at a meal in order to optimize MPS.  Current recommendations are based 
on the assumption that post-prandial increases in plasma amino acids reflect excess 
dietary intake without addressing their metabolic effects on initiating MPS.  We proposed 
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that the post-prandial increase in plasma leu reflects an important metabolic threshold 
that is critical to the anabolic response of a meal (3). This concept has only been tested 
using purified amino acid solutions. In order to test the validity of leu as an indicator of 
protein quality rather than limiting amino acids we propose using whole protein sources 
to create different plasma leu concentrations in order to determine if leu content of a 
protein source is a suitable measure of protein quality and to also determine where 
various thresholds exist for leu to stimulate MPS.   
 We also aim to determine the effect of protein distribution throughout the day on 
maintaining muscle mass. This concept of protein distribution may be a crucial aspect of 
dietary protein intake that the current recommendations do not address. It is likely that to 
optimize muscle mass in adults and prevent age-related muscle dysfunction that protein 
needs should be met by eating multiple high quality protein meals per day with each meal 
containing sufficient leu to reach the threshold and stimulate MPS.  Finally, we will 
examine long term body composition and muscle weight outcomes in response to chronic 
consumption of isonitrogenous, isoenergetic meals containing different leu contents and 
different protein/leu distributions throughout the day to determine if these short term 
meal responses have measureable long term effects.   
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 CHAPTER 2:  The leucine content of a complete meal directs peak activation but 
not duration of skeletal muscle protein synthesis and mammalian target of 
rapamycin signaling in rats1  
 
Introduction 
Leucine (Leu) is known to be a unique regulator of muscle protein synthesis 
(MPS) and translation initiation and has been proposed as a key mechanism translating 
diet quality into the meal response of MPS (1,2).  Leu alone can stimulate MPS to the 
same extent as a complete protein or complete mixture of amino acids by activating 
several factors involved with initiating mRNA translation, primarily through the 
mammalian target of rapamycin (mTOR) signaling pathway, including ribosomal protein 
S6 kinase (S6K), and eukaryotic initiation factor 4E binding protein-1 (4E-BP1) in a dose 
dependant fashion (3,4).   
While leu’s stimulatory effects on MPS and translation initiation have been 
extensively documented in vivo using purified solutions, the impact of leu when 
consumed as part of complete meals is unknown.  Further, neither the relationship of leu 
in complete meals on the post-prandial time course of MPS nor the impact of meals 
containing isonitrogenous protein sources with different leu contents on MPS have not 
been investigated.   
The time course of MPS in response to an oral dose of free leu has been 
previously demonstrated by Anthony et al (4) with synthesis peaking from 30 to 60 min 
after leu administration and returning to control levels by 120 min.  The ability of leu to 
stimulate MPS suggests that leu content may be an important criterion for defining 
optimum protein quantity and quality for a meal. Low protein meals (~10 g/meal) with 
limited leu content produce minimal increases in plasma leu in humans as compared to  
 
___________________ 
1 Norton LE, Layman DK, Bunpo P, Anthony TG, Brana DV, Garlick PJ. The leucine content of a 
complete meal directs peak activation but not duration of skeletal muscle protein synthesis and 
mammalian target of rapamycin signaling in rats. J Nutr. 2009 Jun;139(6):1103-9.  The American 
Society for Nutrition grants the rights to the author(s) for any research article published in the Journal of 
Nutrition to be reprinted in the author(s) thesis. 
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 higher protein meals (~30 g/meal) (5). It is not well understood if feeding isonitrogenous 
complete meals with different leu contents produces differences in plasma leu, translation 
initiation, mTOR signaling and MPS.  
The goal of this study was two-fold:  first, to define the time course of plasma and 
intracellular leu concentrations following consumption of a complete meal containing a 
leu-rich protein source designed to produce a large plasma leu response and to correlate 
these responses with mTOR signaling, translation initiation factors and MPS. Second, to 
assess how complete meals containing 3 different levels of wheat or whey proteins (10, 
20, and 30% of total energy) with different leu contents (6.8% and 10.9% leu 
respectively) impact plasma amino acid profiles, mTOR signaling and MPS. 
 
Materials and Methods 
Animals and diets.   
The animal facilities and protocol were reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of Illinois at Urbana-Champaign. 
Experiment 1 examined the time course of changes in plasma leu, MPS and 
translation initiation factors after a meal.  Male Sprague-Dawley rats (300 ± 15g; Harlan-
Teklad, Indianapolis, IN) were maintained at 24°C with a 12-h light:dark cycle and free 
access to water. Rats were fed diets providing 20/50/30% of energy from whey protein, 
carbohydrates and fats, respectively (Table 2.1).   
Rats were trained to meal feed using 3 meals per day consisting of a small (4 g) 
meal consumed between 07:00 and 07:20 followed by free access to diets from 13:00 to 
14:00 and 18:00 to 19:00 (5).  Rats consumed ~19 g/d of total diet. After 5 d of meal 
training, rats were food deprived for 12 h (from 19:00 until 07:00) and then examined at 
6 time points: prior to the first meal (time 0) and at 45, 90, 135, 180 and 300 min after the 
4g meal. At the indicated times, rats were killed and blood and tissue samples collected. 
Gastrocnemius, soleus, and plantaris muscles were excised and immediately frozen in 
liquid nitrogen for later analysis.    
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Experiment 2 compared the potential of wheat protein vs. whey protein to 
stimulate MPS and translation initiation in skeletal muscle at three levels of protein 
intake (10, 20, and 30% of energy from protein) at 90 min after the test meal representing 
the peak level of MPS observed in Experiment 1. The two protein sources were selected 
to provide the same amount of total nitrogen with different levels of leu.  Leu accounts 
for approximately 10.9% of the total amino acids in whey protein and 6.8% in wheat 
gluten (Table 2.2). Male rats (250 ± 12g) were maintained similar to Experiment 1 except 
they were adapted to meal feeding using a control diet providing 14/56/30% of energy 
from whey protein, carbohydrates and fats, respectively (Table 2.1). After 5d of meal 
feeding rats were randomized into either control (n=7) or one of the 6 treatment groups: 
10% wheat protein (n=8), 10% whey protein (n=8), 20% wheat protein (n=8), 20% whey 
protein (n=8), 30% wheat protein (n=8) and 30% whey protein (n=8) (Tables 1 and 2). 
Wheat gluten diets were supplemented with lysine to meet NRI requirements and to 
approximate whey lysine levels (Table 1).  Rats were food deprived for 12 h and then 
provided a single 4g test meal from one of the 6 experimental diets. The test meals 
contained approximately 0, 29, 47, 60, 94, 89 and 142 mg of leu respectively for the 
control, 10% wheat, 10% whey, 20% wheat, 20% whey, 30% wheat and 30% whey 
groups.  Rats were killed 90 min after consumption of the meal and blood and tissue 
samples collected.  
 
Determination of Muscle Protein Synthesis.  
Protein synthesis was measured in skeletal muscle using the flooding dose method 
(7). A 40% enriched L-[2H5]phenylalanine solution (150mmol/L; Cambridge Isotopes, 
Andover, MA) was administrated at 150 µmol/100 g body weight and injected via tail 
vein (1 mL/100g body weight). After 10 min animals were killed by decapitation and 
hind limbs quickly removed and immersed in an ice-water mixture. Gastrocnemius, 
plantaris, and soleus muscles were removed from cooled hind limbs, frozen in liquid N2 
and stored at –80°C. 
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Frozen muscle tissue was powdered in liquid nitrogen, and protein was 
precipitated with cold (4°C) perchloric acid (30 g/L, 1mL per 50 mg muscle tissue). The 
resulting supernatant and protein pellet were prepared for analysis by gas chromatography 
mass spectroscopy as described previously (8,9).  The enrichment of L-
[2H5]phenylalanine in the muscle hydrolysate was measured by GC-MS using a 6890N 
GC and a 5973N mass detector (Agilent Technologies Santa Clara, CA). The samples 
were run under electron impact ionization and in splitless mode, and phenylethylamine 
ions at mass-to-charge ratio (m/z) 106 (m + 2) and 109 (m + 5) were monitored for 
enrichment analysis.  
The muscle supernatant was used for determination of intracellular free 
phenylalanine enrichment.  Free amino acids were purified by ion exchange resin solid 
phase extraction (SPE) using EZ:faastTM amino acid analysis sample testing kit 
(Phenomenex Inc. Torrance, CA, USA) and 2H5-phenylalanine enrichment was 
determined using a propyl chloroformate derivative with GC-MS by monitoring the ions 
at m/z 206 (m) and 211 (m+5) (10).  
Fractional rates of protein synthesis (FSR) were assessed from the rate of 
incorporation of L-[2H5]phenylalanine into total mixed muscle protein as described 
previously (11). The time from injection of the metabolic tracer until tissue cooling was 
recorded as the actual time for L-[2H5]phenylalanine incorporation.  FSR, defined as the 
percentage of tissue protein renewed each day, were calculated according to the formula:  
FSR=(Eb x 100)/(Ea x t) where t is the time interval between injection and cooling of 
sampled tissue expressed in days and Eb and Ea are the enrichments of [2H5]Phe in 
hydrolyzed tissue protein and in muscle free amino acids, respectively. 
 
Plasma measurements.  
Plasma was obtained from trunk blood by centrifugation at 1800 x g for 10 min at 
4°C. Plasma insulin concentrations were analyzed using a commercial RIA kit for rat 
insulin (Linco Research, MO).  Plasma glucose (Thermo Fisher Scientific, Middletown, 
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VA) was determined by the glucose oxidase method.  Plasma amino acid concentrations 
were analyzed by HPLC using a Waters 2475 Fluorescence detector (12).   
 
Quantitation of eIF4E, 4E-BP1·eIF4E, and eIF4G·eIF4E complexes.  
The association of 4E-BP1 and eIF4G with eIF4E in muscle extracts was 
examined by protein immunoblot analysis as previously described (6,13). Membranes 
were blotted using a rabbit polyclonal antibody to either eIF4E (Santa Cruz 
Biotechnology), eIF4G (Bethyl Labs), or 4E-BP1 (Bethyl Labs).  
 
Phosphorylation of 4E-BP1 and S6K.  
Muscle supernatants were subjected to protein immunoblot analysis as described 
previously (6,13) using a rabbit polyclonal antibody to 4E-BP1 (Bethyl Labs, 
Montgomery, TX) and a rabbit polyclonal S6K antibody (Bethyl Labs, Montgomery, 
TX).  
 
Statistical analysis.   
All data were analyzed by SPSS 15.0 software package for windows.  A 1-way 
ANOVA was performed with the post prandial time as the independent variable for 
experiment 1.  A 2-way ANOVA was performed with treatment group as the independent 
variable for experiment 2.  When a significant overall effect was detected, differences 
among individual means were assessed using Fisher’s LSD post hoc test.  Separate 
comparisons to baseline were made using a t-test.  All data sets were tested for normal 
distribution and variance homogeneity using Levene’s test.  When variances were not 
homogeneous, means were compared using a Games-Howell test.  Correlation between 
data was determined by linear regression (Pearson’s correlation).  The level of 
significance was set at P<0.05 for all statistical tests.  Values in the text are means ± 
SEM.   
 
 
 16 
 
 
Results 
Experiment 1 
 Time course changes in MPS, plasma leu and the activity of protein factors 
involved in regulating mRNA translation were examined at 0, 45, 90, 135, 180 and 300 
min in rats after consuming a 4g complete meal containing 20% whey protein (providing 
~94 mg of leu). MPS increased from 0 to 45 min after the meal and reached peak values 
at 45 and 90 min post-prandial (Figure 2.1).  From 90 to 135 minutes MPS values  
decreased significantly and returned to baseline values at 180 min.   
Plasma leu increased at 45 min after the meal and remained elevated through 300 
min with peak values from 45 to 180 min (Figure 2.1A).  Intracellular leu concentrations 
changed in a pattern similar to plasma leu (Figure 2.2B). Plasma isoleucine, valine, 
lysine and methionine followed similar post-prandial patterns and concentrations returned 
to baseline by 300 min (Table 2.3).  
 Plasma insulin concentrations increased significantly at 90 min (Table 2.3) then 
returned to baseline by 180 min. Plasma glucose was not different from baseline at any 
point during the time course (data not shown).    
 Time course changes in 4E-BP1 and S6K were measured to evaluate the mTOR 
signaling pathway. Both 4E-BP1 (Figure 2.3A) and S6K (Figure 2.3B) phosphorylation 
increased between 45 min and 180 min.  At 300 min both 4E-BP1 and S6K 
phosphorylation declined from peak activation with 4E-BP1 not different from baseline 
while S6K phosphorylation remained at ~50% of peak activation. 
 Formation of the eIF4F translation initiation complex was evaluated by 
determining the association of eIF4E with eIF4G.  Association of eIF4E with eIF4G 
increased between 90 and 180 min (P<0.05 at 90, 135 min, p=0.055 at 180 min; Figure 
2.3C), and returned to baseline at 300 min.   
 Changes in MPS highly correlated with plasma and intracellular leu levels during 
the early post-prandial period. From 0 to 90 min after the meal, plasma leu correlated 
(p<0.001) with activation of S6K (r=0.858), 4E-BP1 (r=.802) and MPS (r=0.782). The 
correlation of plasma leu with MPS was less strong from 90 to 300 min post-prandial 
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(r=0.492, p<0.01).  MPS had a weak correlation with plasma insulin over time (r=0.424, 
p<0.01). 
 
Experiment 2 
Experiment 2 compared the potential of wheat protein vs. whey protein at three 
dietary levels of protein intake (10, 20, and 30% of energy from protein) to stimulate 
MPS and translation initiation in skeletal muscle at 90 min representing the peak level of 
post-prandial MPS observed in Experiment 1. Plasma leu increased significantly above 
food-deprived controls in 10% whey but not 10% wheat (Figure 2.4).  Within the 10%, 
20%, and 30% protein treatment groups, whey protein produced higher plasma leu 
concentrations than wheat except for the 30% group.  Plasma concentrations of isoleucine 
and valine were also greater in the whey groups as compared to the wheat groups except 
at the 30% protein level (Table 2.4).  Plasma concentrations of lysine, methionine, and 
threonine were not different between wheat and whey for any of the groups examined 
with the exception of methionine which was significantly lower in the 10% wheat group 
compared to the 10% whey group (Table 2.4).  Plasma lysine and threonine increased 
above baseline at the 20 and 30% protein levels (P<0.05) with no significant difference 
between whey and wheat.   
 Phosphorylation of 4E-BP1 (Figure 2.5A) and S6K (Figure 2.5B) increased after 
all test meals. However, whey protein promoted mTOR signaling greater than wheat 
protein at nearly all protein levels.  
 MPS increased after all meals except the 10% wheat group (Figure 2.6).  
Consistent with mTOR signaling targets 4E-BP1 and S6K, the main effect was whey 
protein increased MPS more than wheat protein at equal protein intakes with the greatest 
individual differences observed in the 10% (P<0.05) and 30% (P=0.062) protein groups 
where whey stimulated MPS 52% and 19% more than wheat respectively.  
 Plasma insulin concentrations were increased after the meals except for 10% 
whey and 20% wheat (P<0.05).  Peak values were obtained in the 20% whey and 30% 
wheat groups (Table 4).  
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Discussion 
These experiments evaluated time course changes and peak activation in MPS, 
translation factors, and changes in plasma amino acids in response to nutritionally 
complete meals with the purpose of determining the contribution of leu to directing 
postprandial changes in MPS.  The major conclusion of this work is that leu is the 
primary factor directing post-prandial translation factor signaling and peak stimulation of 
MPS, but that the duration of the meal response in skeletal muscle is influenced by 
factors in addition to leu concentrations.      
Experiment 1 examined the time course of MPS after a meal containing 20% of 
energy from whey protein. MPS increased above baseline levels by 45 min with a peak 
value at 90 min and return to baseline at 3 h post-prandially.  Previous research using 
purified amino acids demonstrated a more rapid MPS response that peaked at 45 min and 
returned to baseline by 2 h (3,4,15). Thus, feeding a complete meal appears to both delay 
and prolong MPS in skeletal muscle compared to oral intake of leu or EAA (3, 4).    
These results provide support for the role of leu as a key trigger for post-prandial 
stimulation of MPS after a complete meal but indicate that elevated plasma leu is not 
sufficient to produce sustained elevations of MPS. The cause of MPS becoming 
refractory to plasma leu could not be explained by the mTOR targets 4E-BP1 and S6K as 
they remained activated at 180 min post-prandial.  Likewise, the rate-limiting step of 
eIF4F assembly, eIF4E binding to eIF4G is increased above baseline at 135 min, a point 
at which MPS is decreasing from peak activation.   
The mechanism for the post-prandial decline in MPS with elevated leu is 
unknown (16). Layman and Wisont (17) demonstrated that leu infusion in rats stimulated 
MPS but prolonged infusion depleted plasma valine and isoleucine in proportion to the 
rate of substrate use for MPS. Co-infusion of valine and isoleucine prevented plasma 
depletion. Likewise, Escobar et al (18) reported that leu infusion in neonatal pigs 
depleted plasma EAA coincident with a decline in MPS. These investigators found that 
infusion of a complete mixture of EAA maintained MPS. Contrary to these findings, 
Bohe et. al. (16) documented the refractory nature of skeletal muscle to elevations of 
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amino acids during a 6 h infusion of a complete mixture of EAA in adults.  The infusion 
produced constant elevations in plasma EAA however, the synthetic response lasted only 
2 h and was unable to be further stimulated by infusion of additional EAA during the 6 h 
period. Likewise, in the current experiment, the refractory response to leu occurred 
without a parallel decline in other EAA.    
Another potential mechanism for the refractory response may include plasma 
insulin.  Insulin is not required to stimulate protein synthesis in adults, but it does 
optimize the MPS response of muscle to amino acids (4,19).  Bohe et al. (16) found that 
that plasma insulin time course somewhat paralleled the decline in MPS.  Based on this, 
perhaps an elevation in insulin is necessary to sustain the anabolic response of MPS 
associated with elevated plasma leu.  If insulin contributes to the duration of MPS in the 
current study, the mechanism appears to be independent of insulin’s effects on the 
translation initiation as phosphorylation of 4E-BP1 and S6K remained elevated at 180 
min where MPS and plasma insulin declined to baseline.  The correlation of plasma 
insulin with MPS was statistically significant over the time course but less than the 
correlation between leu and MPS. Insulin is also known to stimulate peptide elongation in 
skeletal muscle (20).  Changes in plasma insulin concentrations may contribute to the 
refractory period of MPS through changes in peptide elongation.  Taken together, current 
information is insufficient to explain why skeletal muscle becomes refractory to the 
anabolic effects of elevated amino acids.  
 Experiment 2 examined responses of translation initiation and MPS to 
isonitrogenous meals with different leu contents. MPS and translation initiation are 
known to respond in a dose relationship to leu administration (3,4), but to our knowledge, 
this was the first experiment to explore dosing leu as a component of different protein 
sources in complete meals.  Overall, whey protein with high leu content was superior to 
wheat protein in initiating MPS in rats fed complete meals.  These findings are consistent 
with a previous report showing that whey protein fed after exercise stimulated mTOR 
signaling to a greater extent than soy protein (6). 
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In accordance with the leu contents of wheat and whey protein, plasma levels of 
leu were greater at every level of protein intake for animals fed whey vs. wheat protein.  
Interestingly, feeding rats the 4g meal containing 10% wheat protein (approximately 
29mg leu) failed to increase plasma leu levels.  Consistent with the plasma data, 10% 
wheat did not stimulate MPS.  Conversely, feeding a meal containing 10% whey 
(approximately 47mg leucine) almost doubled plasma leu levels and significantly 
increased MPS suggesting a minimum threshold of leu intake to increase plasma leu 
concentration and initiate MPS after 90 minutes. Further, at 10% protein intake, 4E-BP1 
and S6K were phosphorylated to a greater extent by whey protein than wheat protein.  
Interestingly, 10% wheat protein stimulated phosphorylation of 4E-BP1 and S6K above 
baseline values despite the lack of increase of plasma leu.  This may be attributed to the 
rise in plasma insulin in the 10% wheat group which is also known to activate the mTOR 
pathway but to a reduced level in the absence of leu (19). 
 A second factor that may contribute to differences in the post prandial rise in 
plasma amino acids is the rate of gastric emptying and peptide digestion and absorption 
(21).  Whey proteins which are highly soluble empty rapidly from the stomach compared 
with casein (21); so it is possible that whey and wheat proteins may empty at different 
rates which could impacted post prandial plasma leu, MPS, and mTOR signaling 
responses.  However, research from Bos et al. (21) demonstrated that plasma amino acids 
peak at approximately 60 min post prandially in humans which is similar to the reported 
amino acids peak for whey protein in humans (22). This is consistent with the observed 
post prandial plasma leu concentrations which are in proportion to the actual leu content 
of each protein.  
The time course of stimulation of MPS after a meal and the refractory nature of 
the anabolic response at 3 h provokes the question as to whether a second stimulation can 
be achieved with a new meal.  Along these lines, these data suggest that the meal 
distribution of protein throughout the day is an important factor to consider in future 
experiments.  Current dietary guidelines for protein make no mention of distribution of 
intake throughout the day.  Data from de Castro (23) indicate that Americans consume 
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over 65% of their daily protein after 18:30 h.  It is unlikely that they reach a threshold of 
protein intake necessary to stimulate MPS at meals prior to 18:30.  Research from Arnal 
et al. (24) also supports the importance of a protein threshold at meals.  Furthermore, if 
the anabolic response to a high protein meal only lasts 3 h, then it is likely that a large 
portion of the day is spent in a catabolic state.  This suggests that optimum protein 
intakes for adults require proteins rich in leu to be provided in multiple meals throughout 
the day.    
 
Conclusions 
In summary, these data suggest that leu content of various protein sources is an 
important indicator of protein quality as it relates to acute stimulation of MPS.  These 
data also provide further evidence that a specific threshold of leu intake is needed to 
initiate mRNA translation and MPS and that low intake of some protein sources may not 
reach this threshold.  Additionally, these data lead us to propose that the distribution of 
protein and specifically leu intake throughout the day is an important factor to optimize 
the muscle anabolic response to each meal.   
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Tables and Figures 
Table 2.1  Composition of test diets 
Component 
Baseline 
Diet1 
10% 
Wheat 
10% 
Whey 
20% 
Wheat 
20% 
Whey2 
30% 
Wheat 
30% 
Whey 
   
 
g/kg     
 
Vital Wheat Gluten3 0.0 132.0 0.0 256.0 0.0 378.0 0.0 
 
L-Lysine supplement4 0.0 7.2 0.0 14.4 0.0 21.6 0.0 
 
Whey Protein Isolate5 159.6 0.0 115.2 0.0 228.0 0.0 340.6 
 
Cornstarch 357.4 377.8 401.8 246.6 290.0 117.4 176.4 
 
Maltodextrin 134.1 134.1 134.1 134.1 134.1 134.1 134.1 
 
Sucrose 101.5 101.5 101.5 101.5 101.5 101.5 101.5 
 
Soybean Oil 140.9 140.9 140.9 140.9 140.9 140.9 140.9 
 
Cellulose (Fiber) 53.7 53.7 53.7 53.7 53.7 53.7 53.7 
 
Mineral Mix6 37.6 37.6 37.6 37.6 37.6 37.6 37.6 
 
Vitamin Mix6 10.7 10.7 10.7 10.7 10.7 10.7 10.7 
 
Choline Bitautrate 2.7 2.7 2.7 2.7 2.7 2.7 2.7 
1Diet used to adapt animals to meal feeding in experiment 2. 
2Diet used in experiment 1. 
3Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  75.5% protein, 15.5% 
carbohydrate, 9% other. 
4Vital Wheat Gluten supplemented with 6.3g L-lysine/100g protein to match Whey Protein Isolate.   
5Whey Protein provided by Perham, Perham, MN.  92.1% protein, 1.6% carbohydrate, 6.3% other.  
6Mineral and Vitamin supplements (25) from Harlen-Teklad, Madison, WI. 
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Table 2.2  Amino acid compositions of protein sources 
Amino Acid Wheat1   Whey2  
 
 g/100g protein    
 
Alanine 3.1       4.9 
 
Arginine 4.7       2.4 
 
Aspartate 4.0       10.6 
 
Cysteine 1.9       2.5 
 
Glutamate/Glutamine 31.7       16.9 
 
Glycine 3.8       1.8 
 
Histidine 1.8       2.0 
 
Isoleucine 3.0       6.2 
 
Leucine 6.8       10.9 
 
Lysine3 2.8 (+6.3)       9.1 
 
Methionine 1.9       2.0 
 
Phenylalanine 4.4       3.3 
 
Proline 9.4       5.6 
 
Serine 3.9       4.7 
 
Threonine 2.6       6.4 
 
Tryptophan 1.3       1.7 
 
Tyrosine 2.4       3.0 
 
Valine 4.5       6.0 
1Vital Wheat Gluten purchased from Harlan Teklad, Madison, WI.  76% protein, 15.2% carbohydrate, 
8.8% other. 
2Whey protein isolate provided by Perham, Perham, MN.  92.1% protein, 1.6% carbohydrate, 6.3% other. 
3Wheat Gluten supplemented with 6.3g L-lysine/100g protein to match whey protein.  
 
 24 
 
 
Table 2.3  Time course changes in selected essential amino acid and insulin concentrations in rats fed a complete meal1 
Time (min) 02 45 90 135 180 300 
   µmol/L    
Leucine     83.6 ± 4.6c 265 ± 11.6a 261 ± 17.4a 255 ± 21.3 a 258 ± 19.0a 152 ± 15.1b 
Isoleucine 55.6 ± 2.8b 121 ± 5.5a 111 ± 8.9a 108 ± 14.9ab 108 ± 9.8a 93.2 ± 6.6ab 
Valine 143 ± 8.9b 227 ± 5.5a 223 ± 13.4a 227 ± 13.5a 235 ± 14.6a 159 ± 13.4b 
∑ BCAA 282 ± 16.0b 615 ± 21.3a 595 ± 39.0ab 591 ± 67.6ab 602 ± 42.9ab 372 ± 43.6b 
       
Lysine 472 ± 26.8c 1074 ± 176.9bc 855 ± 91.6ab 852 ± 50.7ab 647 ± 38.0ab 385 ± 7.3c 
Methionine 27.0 ± 1.1c 52.3 ± 3.0a 43.9 ± 3.1a 41.7 ± 4.6ab 34.6 ± 2.8bc 30.7 ± 2.1bc 
Threonine 556 ± 61.0b 840 ± 65.9a 843 ± 43.2a 921 ± 57.8a 917 ± 64.2a 785 ± 48.3a 
 
Insulin, pmol/L 77.3 ± 14.9b 89.0 ± 15.7b 156 ± 36.1a 137 ± 17.3ab 90.2 ± 9.2b 96.2 ± 6.6b 
1Values expressed as means  ± SEM, n=5-6.  Labeled means without a common letter differ (P<0.05). 
212 hour food-deprived controls. 
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Table 2.4  Selected plasma essential amino acid and insulin concentrations 90 min after feeding complete meals containing wheat or whey1 
  
 
Baseline2 10% Wheat 10% Whey 20% Wheat 20% Whey 30% Wheat 30% Whey 
 
Leucine 83.1 ±  4.8 76.9 ± 3.9d 149.5 ± 11.0c 180.7 ± 10.3c 242.3 ± 12.2b 350.7 ± 27.3ab 442.8 ± 12.2a 
 
Isoleucine 44.5 ± 2.3 50.6 ± 2.5d 101.5 ± 9.3c 121.5 ± 9.8bc 155.1 ± 12.7b 223.7 ± 19.6ab 257.5 ± 17.5a 
 
Valine 118.0 ± 4.6 83. 6 ± 4.4c 190.5 ± 18.2b 211.2 ± 13.4b 319.8 ± 35.3ab 430.7 ± 39.1a 505.4 ± 40.1a 
 
∑ BCAA 245.6 ± 11.0 211.1 ± 10.4c 441.5 ± 37.4b 513.4 ± 32.2b 717.3 ± 51.1ab 967.8 ± 77.2a 1177.2 ± 84.2a 
 
        
 
Lysine 449.3 ± 39.9 394.5 ± 26.1b 530.1 ± 65.0ab             663.7 ± 69.5ab 821.8 ± 84.4a 705.1 ± 70.1ab 658.2 ± 49.8ab 
 
Methionine 44.1 ± 3.9 31.0 ± 0.9c 46.8 ± 3.8ab 60.2 ± 6.4ab 59.8 ± 4.6ab 70.9 ± 7.0a 77.9 ± 8.8a 
 
Threonine 568.2 ± 53.1 536.2 ± 46.6c 670.6 ± 109.2bc 766.3 ± 74.2b 902.4 ± 85.8ab 1038.3 ± 88.3a 1024.6 ± 71.4a 
 
        
Insulin pmol/L 76.4 ± 6.5 142.7 ± 15.9ab 119.0 ± 24.3b 118.1 ± 21.1b 178.4 ± 20.2a 171.7 ± 22.5ab 134.6 ± 18.1ab 
1Values expressed as means ± SEM, n=6-8.  Main effects for wheat vs. whey were significant.  Labeled means without a common letter differ (P<0.05). 
212 hour food-deprived control.  
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Figure 2.1  Time course changes in the fractional rate of protein synthesis in 
gastrocnemius muscle of rats fed a 4g complete meal containing 20%, 50%, and 30% of 
energy from protein, carbohydrates and fats, respectively.  Data are means ± SEM; n = 5-
6.  Labeled means without a common letter differ, P<0.05. 
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Figure 2.2  Time course changes in plasma (A) and intramuscular (B) leucine 
concentrations of rats fed a 4g complete meal containing 20%, 50%, and 30% of energy 
from protein, carbohydrates and fats, respectively.  Data are means ± SEM; n = 5-6.  
Labeled means without a common letter differ, P<0.05. 
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Figure 2.3  Time course changes in the phosphorylation state of 4E-BP1 (A), p70S6K 
(B), and binding of eIF4G to eIF4E (C) in gastrocnemius muscle of rats fed a 4g 
complete meal containing 20%, 50%, and 30% of energy from protein, carbohydrates and 
fats, respectively.  Data are means ± SEM; n = 5-6.  Labeled means without a common 
letter differ, P<0.05. 
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Figure 2.4  Plasma leucine concentrations of rats fed complete meals containing either 
wheat or whey at three different total protein contents (10,20, or 30% of energy).  Data 
are means ± SEM; n = 7-8.  Labeled means without a common letter differ, P<0.05.  All 
fed groups were different than baseline except 10% wheat. 
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Figure 2.5  Phosphorylation states of 4E-BP1 (A) and p70S6K (B) in gastrocnemius 
muscle of rats fed a complete meal containing either wheat or whey (grey bars) at three 
different total protein contents (10,20, or 30% of energy).  Data are means ± SEM; n = 7-
8.  Labeled means without a common letter differ, P<0.05.  All fed groups were different 
than baseline. 
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Fig. 2.6 Rates of protein synthesis in gastrocnemius muscle of rats fed a complete meal 
containing either or whey at three different total protein contents (10, 20, or 30% of 
energy).  Data are means ± SEM; n = 7-8.  Labeled means without a common letter 
differ, P<0.05.  All fed groups were different than baseline except 10% wheat. 
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CHAPTER 3:  Isonitrogenous protein sources differentially stimulate skeletal 
muscle protein synthesis in adult rats fed complete meals based on their respective 
leucine contents 
 
Introduction 
Leucine (leu) is unique among amino acids as a modulator of the mTOR 
(mammalian target of rapamycin) signaling cascade and regulator of muscle protein 
synthesis (MPS). Numerous in vivo studies have demonstrated that oral or intravenous 
administration of free leu stimulates mTOR activation of translation initiation factors 
eIF4E-BP1 (4E-BP1), eIF4G, and ribosomal protein S6 kinase (S6K). Titration studies of 
leu regulation of MPS indicate that leu stimulation of mTOR is dependent on increases in 
intracellular leu concentrations and that this stimulation requires at least 2- to 3-fold 
increases in plasma leu above baseline (i.e. food deprived) amino acid values (1, 2). 
While the threshold response of mTOR and MPS to plasma leu concentrations is 
established from studies using free leu, the significance of this threshold activation in 
physiological complete meals is unknown.  
Individual proteins differ in many characteristics including amino acid contents. 
Current measures of protein requirements are based on a daily intake of the minimum 
protein to maintain nitrogen balance and to prevent increases in plasma amino acids 
stimulating amino acid oxidation. These measurements focus on the lysine, methionine, 
and threonine contents of proteins as the most limiting of the indispensable amino acids. 
Leu is abundant in most proteins and is unlikely to be limiting based on nitrogen balance 
or amino acid oxidation measurements. However, our previous research demonstrated a 
clear dietary threshold for leu stimulation of MPS (2). To our knowledge, the significance 
of leu content of different proteins in complete meals on MPS has not been examined. 
This study utilizes a meal-feeding protocol with adult rats to examine the 
importance of the leu content of a meal on postprandial changes in plasma leu, activation 
of S6K and 4E-BP1, and MPS. The test meal was designed to represent a small breakfast 
meal (20% of daily energy) with a complete mixture of macronutrients (16% of energy 
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from protein, 54% carbohydrates, 30% fats) and consumed after an overnight period of 
food deprivation (12 h). Four proteins (wheat gluten, soy isolate, egg white, and whey 
protein isolate) were selected to provide a range of indispensable amino acid 
concentrations with leu ranging from 6.8% to 10.9% (w/w). Based on studies with free 
leu, we predict that the postprandial MPS response will be determined by the leu content 
of the individual meals.   
 
Materials and Methods 
Animals and diets.   
Male rats (250 ± 12g) were purchased from Harlan-Teklad and maintained at 
24°C with a 12-h light:dark cycle and free access to water.  The animal facilities and 
protocol were reviewed and approved by the Institutional Animal Care and Use 
Committee of the University of Illinois at Urbana-Champaign. 
Rats were trained to consume 3 meals/d consisting of a 4 g meal consumed 
between 07:00 and 07:20 h followed by free access to food from 13:00 to 14:00 and 
18:00 to 19:00 (3).  Rats consumed ~17 g/d of total diet.  After 2 d of adaptation to meal 
feeding, rats were randomized into treatment groups based on body weight.  All diet 
treatments provided 16/54/30% of energy from protein, carbohydrates and fats, 
respectively with the treatments differing in source of protein: wheat (n=10), soy (n=10), 
egg (n=11), or whey protein (n=11) (Table 3.1). Wheat gluten diets were supplemented 
with lysine to exceed the minimum National Research Council (NRC) requirement 
(Table 3.2) and to equal the lysine content of whey protein (Table 3.3). A baseline food-
deprived control group was also adapted to meal-feeding using whey protein (n=10).  
Rats were fed the respective diets for 14 d.  On the experiment day rats were food 
deprived for 12 h and then fed their normal 4g breakfast meal.  The food-deprived 
controls received no breakfast meal.  The breakfast meals contained 0, 46, 54, 60, and 74 
mg of leu, respectively, for the food-deprived controls, wheat, soy, egg, and whey groups.  
Rats were killed 90 min after consumption of the meal and blood and tissue samples 
collected.  
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Determination of Muscle Protein Synthesis.  
Protein synthesis was measured in skeletal muscle using the flooding dose method 
(4). A 100% enriched L-[2H5]-phenylalanine solution (150mmol/L; Cambridge Isotopes, 
Andover, MA) was administrated at 150 µmol/100 g body weight and injected via tail 
vein (1 mL/100 g body weight). After 10 min animals were killed by decapitation and 
hind limbs quickly removed and immersed in an ice-water mixture. Gastrocnemius, 
plantaris, and soleus muscles were removed from cooled hind limbs, frozen in liquid N2 
and stored at –80°C. 
Frozen muscle tissue was powdered in liquid nitrogen, and protein was 
precipitated with cold (4°C) perchloric acid (30 g/L, 1mL per 50 mg muscle tissue). The 
resulting supernatant and protein pellet were prepared for analysis by gas chromatography 
mass spectroscopy (GC-MS) as described previously (5, 6).  The enrichment of L-[2H5]-
phenylalanine in the muscle hydrolysate was measured by GC-MS using a 6890N GC and 
a 5973N mass detector (Agilent Technologies Santa Clara, CA). Samples were run under 
electron impact ionization and in splitless mode, and phenylethylamine ions at mass-to-
charge ratio (m/z) 106 (m + 2) and 109 (m + 5) were monitored for enrichment.  
The muscle supernatant was used for determination of intracellular free 
phenylalanine enrichment.  Free amino acids were purified by ion exchange resin solid 
phase extraction (SPE) using EZ:faastTM amino acid analysis sample testing kit 
(Phenomenex Inc. Torrance, CA, USA) and 2H5-phenylalanine enrichment was 
determined using a propyl chloroformate derivative with GC-MS by monitoring the ions 
at m/z 206 (m) and 211 (m+5) (7).  
Fractional rates of protein synthesis (FSR) were determined from the rate of 
incorporation of L-[2H5]-phenylalanine into total mixed muscle protein as described 
previously (8). The time from injection of the metabolic tracer until tissue cooling was 
recorded as the actual time for L-[2H5]-phenylalanine incorporation.  FSR, defined as the 
percentage of tissue protein renewed each day, were calculated according to the formula:  
FSR=(Eb x 100)/(Ea x t) where t is the time interval between injection and cooling of 
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sampled tissue expressed in days and Eb and Ea are the enrichments of [2H5]-Phe in 
hydrolyzed tissue protein and in muscle free amino acids, respectively. 
 
Plasma measurements.  
Plasma was obtained from trunk blood by centrifugation at 1800 x g for 10 min at 
4°C. Plasma insulin concentrations were analyzed using a commercial RIA kit for rat 
insulin (Linco Research, MO).  Plasma glucose (Thermo Fisher Scientific, Middletown, 
VA) was determined by the glucose oxidase method.  Plasma amino acid concentrations 
were analyzed by HPLC using a Waters 2475 Fluorescence detector (9).   
 
Phosphorylation of 4E-BP1, S6K, Akt, and Raptor.  
Muscle supernatants were subjected to protein immunoblot analysis as described 
previously (10, 11) using a rabbit polyclonal antibody to 4E-BP1 (Bethyl Labs, 
Montgomery, TX), a rabbit polyclonal S6K antibody (Bethyl Labs, Montgomery, TX), a 
rabbit polyclonal phospho-Akt antibody (Cell Signaling, Danvers, MA), a rabbit 
polyclonal Akt antibody (Cell Signaling, Danvers, MA), a rabbit polyclonal phospho-
Raptor antibody (Cell Signaling, Danvers, MA), and a rabbit polyclonal Raptor antibody 
(Bethyl Labs, Montgomery, TX).   
 
Statistical analysis.   
All data were analyzed by SPSS 15.0 software package for windows.  A 1-way 
ANOVA was performed with the treatment group as the independent variable.  When a 
significant overall effect was detected, differences among individual means were 
assessed using Fisher’s LSD post hoc test.  All data sets were tested for normal 
distribution and variance homogeneity using Levene’s test.  When variances were not 
homogeneous, means were compared using a Games-Howell test.  The level of 
significance was set at P<0.05 for all statistical tests.  All values are presented as means ± 
SEM.   
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Results 
 This experiment compared isonitrogenous, isoenergetic diets containing wheat, 
soy, egg, or whey as the protein source on the potential to stimulate translation initiation 
and MPS in skeletal muscle.  After a small meal providing 20% of daily energy and 
containing 16% of energy as protein, plasma leu increased in animals fed egg and whey 
proteins but not in wheat and soy groups.  The greatest concentration of plasma leu 
occurred in animals fed whey protein (Table 3.4).  Similar postprandial patterns of 
plasma amino acids concentrations (i.e. whey > egg > soy > wheat) were observed for 
isoleucine and valine with whey producing the highest concentrations at 90 min after the 
meal (Table 3.4).  Other plasma amino acids varied among the groups largely in 
proportion to the amino acid content of the protein source (Table 4). Lysine was different 
between animals fed soy and whey, with animals fed whey having the greatest 
concentration of postprandial lysine and animals fed soy having the lowest lysine levels. 
Plasma methionine concentrations were only increased in animals fed egg with the other 
groups not being different from food deprived controls (Table 3.4).  Plasma threonine 
was increased by feeding egg and whey with peak values achieved in animals fed whey 
protein. 
 MPS increased in animals fed egg and whey but not in animals fed wheat and soy 
with peak values achieved in the whey group (Figure 3.1).  This was consistent with the 
phosphorylation of the mTOR signaling targets 4E-BP1 (Figure 3.2A) and S6K (Figure 
3.2B).  Phosphorylation of S6K increased after egg and whey meals but not wheat and 
soy with peak values obtained in the whey protein group.  Feeding increased 4E-BP1 
phosphorylation in all groups with egg and whey greater than wheat or soy.   
 Akt activation was determined by phosphorylation of Akt at Ser473.  Akt 
phosphorylation was greatest in animals fed soy compared with animals fed egg, whey, 
or the food deprived controls (Figure 3.3A).  Animals fed wheat had intermediate levels 
of Akt activity and were not different from the other groups.  
Phosphorylation of Raptor at Ser792 is a surrogate marker for AMP protein 
kinase (AMPK) activity and represents inhibition of mTOR (12, 13). Similar to Akt 
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activity, Raptor phosphorylation was greatest in animals fed soy compared to food 
deprived controls and animals fed egg or whey, with animals fed wheat having an 
intermediate level of Raptor phosphorylation compared with soy and the other groups 
(Figure 3.3B).  
 Plasma glucose and insulin were increased at 90 min after the meal in all groups 
except soy which was not different from food deprived controls (Table 3.4). 
 
Discussion 
 This experiment examined responses of MPS, translation initiation, and plasma 
amino acids after feeding nutritionally complete meals with protein sources selected for 
differences in leu content (wheat, soy, egg, and whey). The major finding of this work is 
that isonitrogenous, isoenergetic meals with different protein sources stimulate MPS and 
anabolic signaling in proportion to plasma leu concentrations which relate to the leu 
content of the respective protein.  Previous research demonstrated that MPS and 
translation initiation respond in a dose dependent manner to administration of free leu (1).  
We recently demonstrated that a similar effect could be achieved using different amounts 
of wheat or whey proteins as part of isonitrogenous, isoenergetic complete meals (2).  
This experiment extends these findings and demonstrates that after a small breakfast meal 
with limited protein content, whey and egg proteins increased MPS whereas wheat and 
soy proteins did not. MPS appears to responds to postprandial changes in plasma leu 
concentrations and reflects a precise dietary threshold consistent with the leu content of 
the individual proteins. These findings support the theory of a threshold requirement for 
leu intake to stimulate MPS.   
Consistent with plasma leu and MPS data, S6K phosphorylation increased in the 
groups fed egg and whey by 22% and 58%, respectively, whereas animals fed wheat and 
soy had no increase in S6K phosphorylation.  Phosphorylation of 4E-BP1 increased after 
the meal in all groups with maximum phosphorylation of 4E-BP1 achieved in the egg and 
whey groups.  
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Other factors that may contribute to differences in the postprandial rise in plasma 
amino acids include the rate of gastric emptying and peptide digestion and absorption 
(14).  Whey proteins which are highly soluble empty rapidly from the stomach compared 
with casein (15); so it is possible that wheat, soy, egg, and whey proteins may empty at 
different rates which could impact postprandial plasma leu and mTOR signaling 
responses.  However, Bos et al. (14, 16) reported that plasma amino acids peaked 60-120 
min postprandial in humans fed wheat or soy protein which is similar to the reported 
amino acids peak for whey protein in humans and rats (2, 15). Likewise, Moore et al. (17) 
demonstrated that plasma amino acid levels peaked at approximately 1 h after feeding 
egg albumin in humans after exercise.  Consistent with these reports, postprandial plasma 
leu concentrations at 90 min in the present study are in proportion to the leu content of 
each protein.  
Plasma insulin increased after feeding in all groups except soy potentially 
contributing to the anabolic effect of the meal. Previously, soy protein has been reported 
to reduce postprandial insulin concentrations but still increase Akt phosphorylation (18). 
These findings have been interpreted as increased insulin sensitivity with soy protein 
(16). However, in the present study downstream signaling for S6K activation or 
stimulation of MPS are reduced.  
Failure of the Akt to stimulate downstream signals at S6K or 4E-BP1 may be due 
in part to limiting levels of leu to stimulate mTOR signaling or to stimulation of Raptor 
phosphorylation by AMPK, inhibiting mTOR. The leu content of soy is similar to egg 
(8.0% vs. 8.8%) however postprandial plasma leu is significantly greater after the egg vs. 
soy meals. This finding suggests a precise threshold for leu intake required to produce a 
rise in plasma leu after a meal.   
Alternatively the lack of mTOR stimulation may be confounded by the isoflavone 
content of the soy protein which is reported to inhibit mTOR signaling via stimulation of 
AMPK (18). Increasing AMPK activity stimulates Raptor phosphorylation reported to 
inhibit mTOR signaling reducing the activity of S6K (19).  Further, S6K is known to 
phosphorylate IRS-1 to provide feedback regulation of insulin signaling (20). In the 
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absence of downstream S6k activation, the elevated Akt phosphorylation in the soy group 
may reflect dysregulation of normal feedback from S6K.   
Metabolic differences among proteins may also relate to ratios of other amino 
acids in the protein. For the proteins used in this study only the wheat gluten lysine 
content was below the NRC requirement for the adult rat. This specific requirement was 
corrected by supplementing the wheat gluten diet with lysine to the level of the 
concentration in the whey protein (Table 2). All other EAA exceeded NRC guidelines.  
This study supports the hypothesis that protein distribution at individual meals is 
an important factor for evaluation of adult protein needs (21, 22). Current protein 
requirements establish a total daily intake but provide no guidance about distribution 
throughout the day. The leu content of a meal is important to regulation of MPS. These 
findings highlight that postprandial increases in plasma (or intracellular) leu after a 
complete meal serve as a nutrient signal for regulation of MPS (23, 24).  
 The unique regulatory role of leu may in part explain the inconsistencies in 
comparison of optimal needs for leu compared with current measures of minimum 
protein requirements for nitrogen balance or indispensible amino acid oxidation (IAAO) 
measurements. These standard measurements for protein requirement interpret 
postprandial increases in plasma amino acids as inefficient and excessive protein intake. 
While increased amino acid oxidation may reflect reduced efficiency of nitrogen 
retention of dietary protein and may provide an accurate representation of minimum 
requirements for an EAA such as lysine with no known metabolic signaling or regulatory 
roles, the extrapolation that protein intakes above the minimum amount for short-term 
nitrogen balance are physiologically meaningless is not consistent with the regulatory 
role of leu in MPS.  Further support for this postulation is demonstrated by the close 
association of changes in plasma leu with rates of MPS and leu oxidation (2, 25). 
 
Conclusions 
The current study demonstrates the relationship of the meal content of leu to 
postprandial increases in plasma leu and stimulation of MPS. These findings support the 
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hypothesis that meal distribution of dietary protein is important to adult protein utilization 
and highlights the need for longer-term studies of the potential impact of protein 
distribution on muscle function and body composition.  
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Tables and Figures 
 
Table 3.1  Composition of animal diets 
Component Wheat Diet Soy Diet Egg Diet Whey Diet 
  g/kg   
Vital Wheat Gluten1 190.2 0.0 0.0 0.0 
Soy Protein Isolate2 0.0 185.3 0.0 0.0 
Egg White Solids3 0.0 0.0 195.6 0.0 
Whey Protein Isolate4 0.0 0.0 0.0 188.8 
L-Lysine5 10.1 0.0 0.0 0.0 
Cornstarch 316.7 331.7 321.4 328.2 
Maltodextrin 134.1 134.1 134.1 134.1 
Sucrose 101.5 101.5 101.5 101.5 
Soybean Oil 140.9 140.9 140.9 140.9 
Cellulose (Fiber) 53.7 53.7 53.7 53.7 
Mineral Mix6 37.6 37.6 37.6 37.6 
Vitamin Mix6 10.7 10.7 10.7 10.7 
Choline Bitautrate 2.7 2.7 2.7 2.7 
Biotin7 (mg/kg) 0.0 0.0 16.0 0.0 
1Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  83.4% protein, 7.6% 
carbohydrate, 9% other. 
2Soy Protein Isolate provided by Archer Daniels Midland Company, Decatur, IL.  91.6% protein, 1.4% 
carbohydrate, 7% other.  
3Egg White Solids purchased from Harlan-Teklad, Madison, WI.  87.8% Protein, 4.5% carbohydrate, 7.7% 
other. 
4Whey Protein Isolate provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate, 6.3% other. 
5Vital Wheat Gluten supplemented with 6.3g L-lysine/100g protein to match Whey Protein Isolate.   
6Mineral and Vitamin supplements (26) from Harlen-Teklad, Madison, WI. 
7Egg White Solids supplemented with 16.0 mg biotin/kg diet. 
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Table 3.2  Comparison of test diet amino acid compositions with NRC requirements1,2 
Amino Acid  Wheat Diet Soy Diet Egg Diet Whey Diet NRC 
Requirement 
   g/kg diet    
Phenyalanine/Tyrosine  11.5 17.0 16.8 10.7 1.9 
Histidine  3.1 4.2 3.9 3.4 0.8 
Isoleucine  5.1 8.1 9.0 10.5 3.1 
Leucine  11.5 13.6 14.9 18.5 1.8 
Lysine  15.4 10.7 11.0 15.4 1.1 
Methionine/Cysteine  6.5 4.4 13.9 7.6 2.3 
Threonine  4.4 6.5 7.6 10.9 1.8 
Tryptophan  2.2 2.0 2.7 2.7 0.5 
Valine  7.6 8.0 11.5 10.2 2.3 
1Table 2-2 from Nutrient Requirements of Laboratory Animals Fourth Revised Edition (27). 
2Values calculated for 300 g rat at maintenance. 
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Table 3.3  Amino acid compositions of protein sources 
Amino Acid Vital Wheat Gluten1 
Soy Protein 
Isolate2 
Egg White 
Solids3 
Whey Protein 
Isolate4 
  g/100g Protein   
Alanine 3.1 4.0 6.1 4.9 
Arginine 4.7 7.5 5.8 2.4 
Aspartate 4.0 11.5 10.3 10.6 
Cysteine 1.9 1.3 4.4 2.5 
Glutamate/Glutamine 31.7 19.2 13.1 16.9 
Glycine 3.8 4.1 3.5 1.8 
Histidine 1.8 2.5 2.3 2.0 
Isoleucine 3.0 4.8 5.3 6.2 
Leucine 6.8 8.0 8.8 10.9 
Lysine5 2.8 (+6.3) 6.3 6.5 9.1 
Methionine 1.9 1.3 3.8 2.0 
Phenylalanine 4.4 5.2 5.9 3.3 
Proline 9.4 5.2 3.8 5.6 
Serine 3.9 5.4 6.9 4.7 
Threonine 2.6 3.8 4.5 6.4 
Tryptophan 1.3 1.2 1.6 1.7 
Tyrosine 2.4 4.8 4.0 3.0 
Valine 4.5 4.7 6.8 6.0 
1Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  83.4% protein, 7.6% 
carbohydrate, 9% other. 
2Soy Protein Isolate provided by Archer Daniels Midland Company, Decatur, IL.  91.6% protein, 1.4% 
carbohydrate, 7% other.  
3Egg White Solids purchased from Harlan-Teklad, Madison, WI.  87.8% Protein, 4.5% carbohydrate, 7.7% 
other. 
4Whey Protein provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate, 6.3% other. 
5Vital Wheat Gluten supplemented with 6.3g L-lysine/100g protein to match Whey Protein Isolate.   
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Table 3.4  Selected plasma essential amino acid, insulin, and glucose concentrations 90 min after feeding 
complete meals containing wheat, soy, egg, or whey protein1 
 Baseline2 Wheat Soy Egg Whey 
  µmol/L    
Leucine 84 ± 4.6c 78 ± 4.3c 84 ± 5.6c 146 ± 8.4b 192 ± 11.4a 
Isoleucine 56 ± 3.4d 50 ± 2.9d 74 ± 4.0c 121 ± 6.3b 144 ± 8.2a 
Valine 117 ± 8.2cd 95 ± 5.2d 143 ± 8.1c 143 ± 14.2a 248 ± 13.7b 
∑ BCAA 257 ± 16.0bc 223 ± 12.1c 301 ± 17.4b 562 ± 28.5a 584 ± 33.0a 
      
Lysine 510 ± 29.8ab 527 ± 23.8ab 419 ± 37.2b 495 ± 35.6ab 549 ± 29.3a 
Methionine 51 ± 2.9bc 46 ± 2.8bc 38 ± 4.1c 86 ± 6.8a 52 ± 5.2b 
Threonine 252 ± 13.7c 269 ± 30.4bc 349 ± 40.6bc 357 ± 28.3ab 538 ± 51.2a 
      
Insulin pmol/L 140 ± 10.5b 178 ± 9.0a 161 ± 11.0ab 184 ± 12.0a 170 ± 7.2a 
Glucose mg/dl 128 ± 15.4b 190 ± 37.7ab 116 ± 21.1b 236 ± 33.6a 171 ± 20.1ab 
1Values expressed as means ± SEM, n=8-10.  Labeled means without a common letter differ (P<0.05). 
212 h food-deprived control.  
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Figure 3.1 Rates of protein synthesis in gastrocnemius muscle of rats fed a complete 
meal containing wheat, soy, egg, or whey proteins.  Data are means ± SEM; n = 9-10.  
Labeled means without a common letter differ, P<0.05.   
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Figure 3.2  Phosphorylation states of 4E-BP1 (A) and p70S6K (B) in gastrocnemius 
muscle of rats fed a complete meal containing wheat, soy, egg, or whey proteins.  Data 
are means ± SEM; n = 9-10.  Labeled means without a common letter differ, P<0.05.   
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Figure 3.3  Phosphorylation of Akt at Ser473 (A) and Raptor at Ser792 (B) in 
gastrocnemius muscle of rats fed a complete meal containing wheat, soy, egg, or whey 
proteins.  Data are means ± SEM; n = 9-10.  Labeled means without a common letter 
differ, P<0.05.   
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CHAPTER 4:  Leucine content of isonitrogenous and isoenergetic protein sources 
positively influences long term body composition and muscle mass in rats 
    
Introduction 
Maintenance of muscle mass requires a balance between the rates of protein 
synthesis and breakdown. Together the processes of synthesis and breakdown to called 
protein turnover and the balance ultimately determines muscle mass.  Factors such as 
aging, disease, or energy restriction can decrease MPS and reduce muscle mass by 
disrupting this balance (1-5).  Progressive loss of muscle mass over time can cause a host 
of problems including reduced mobility, quality of life, strength, and the ability to 
perform everyday tasks (6).  It is therefore important to identify dietary factors which 
may positively influence protein synthesis and help maintain muscle mass.  Leu has been 
proposed as a key amino acid regulator of MPS.  Indeed, several studies have 
demonstrated leu’s unique anabolic signaling effects on MPS using purified amino acid 
solutions (7, 8).   
Our research group has previously demonstrated that the leu content of 
isonitrogenous meals predict the postprandial response of MPS (9).  Interestingly, further 
research demonstrated that a specific threshold amount of leu at a meal is required to 
increase plasma leu and increase MPS.  Previously we demonstrated that small breakfast 
meals containing wheat and soy with leu contents of 47 mg and 54 mg of leu, 
respectively, were insufficient to increase plasma leu or MPS, whereas isonitrogenous 
meals containing egg and whey with 60 mg and 74 mg of leu, respectively, significantly 
increased plasma leu, initiated mTOR signaling, and triggered MPS.  This is in contrast 
to current recommendations that are based on methods of nitrogen balance, direct amino 
acid oxidation (DAAO), or indispensible amino acid oxidation (IAAO) which consider 
increases in plasma amino acids that result in increases of amino acid oxidation as excess 
and inefficient.  Evidence now exists that increases in plasma amino acids are an essential 
part of the nutritional signal for skeletal muscle to recognize adequate dietary protein to 
initiate MPS.   
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While the experimental data in support of a dietary leu threshold are compelling 
their significance is unclear without long term changes in muscle mass or body 
composition.  Postprandial changes in plasma amino acids, mTOR signaling, and MPS in 
feeding studies have only been shown in short-term studies and it is unclear if these 
effects are maintained long term and if they produce differences in muscle weights.  It is 
also unclear if the daily distribution of protein (i.e. leu) makes a difference on these 
outcomes.  If meal responses are important in determining body composition outcomes, 
then it would logical to suggest subjects consuming sufficient protein to increase plasma 
leu and MPS multiple times per day would be superior to a single meal stimulation.   
The purpose of this experiment was to determine if feeding isonitrogenous protein 
sources with different leu contents can differentially impact long term body composition 
and protein synthesis outcomes and if these outcomes are related to the meal responses of 
plasma leu and MPS.        
Materials and Methods 
Animals and diets.   
Male Sprague-Dawley rats (275 ± 10g; Harlan-Teklad) will be maintained at 24°C 
with a 12-h light:dark cycle and free access to water. The animal facilities and protocol 
were reviewed and approved by the Institutional Animal Care and Use Committee of the 
University of Illinois at Urbana-Champaign. 
 Rats were trained to consume 3 meals/d consisting of a 4 g meal consumed 
between 07:00 and 07:20 followed by free access to food from 13:00 to 14:00 and 18:00 
to 19:00 for 6 days.  Rats consumed ~18 g/d of total diet.  On day 7, rats were 
randomized into the following diet groups (n=21-25): wheat, soy, egg, and whey and 
food-deprived controls (Table 4.1 and Table 4.2).  Wheat protein was supplemented 
with lysine to meet NRC requirements and approximate whey lysine levels (Table 4.2 
and Table 4.3).  The diets were fed at 80% of ad libitum (14 g/day) intake to produce 
changes in body composition. In order to study meal responses and control for between 
animal differences in food intake, rats were fed defined amounts at each meal:  a small (4 
g) first meal consumed between 07:00 and 07:20 followed by a 4 g meal from 13:00 to 
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14:00 and an 6 g meal from 18:00 to 19:00, representing a meal pattern designed to 
mimic human eating behavior (10).  These meals were designed to only increase plasma 
leu & MPS 1x/day for animals fed wheat and soy, but 3x/day for animals fed egg and 
whey based on data from Chapter 3 (summarized in Table 4.4).  This was designed to 
test the theory the multiple stimulations of MPS are superior to a single stimulation.  
Each of the diets provided 16% of energy from protein. Total daily protein, carbohydrate, 
and lipid intakes were the same for all groups (Table 4.3).   
 After 2 wk of meal feeding treatment diets approximately half of the rats in each 
treatment group were set aside for determination of body composition by DXA (Dual 
energy X-ray absorptiometry). These animals were then allowed to recover and continue 
meal feeding for the remainder of the study.   
 Also at 2 wk, the remaining animals in each group that did not undergo DXA 
were used for measurement of MPS.  Animals were food deprived for 12 h and then MPS 
determined before the first meal (i.e. food-deprived group) or 90 min after completion of 
the normal breakfast meal.  The meals contained approximately 46, 54, 60, and 74 mg leu 
in the wheat, soy, egg, and whey groups respectively (Table 4.4).  90 min after 
consumption of the meal rats were killed and blood and tissues harvested.  Tissues 
weighed and collected included the gastrocnemius, soleus, and plantaris muscles, and 
liver.  The animals used for DXA at 2 wk continued on the diet treatments for 9 more 
weeks and then underwent DXA and were sacrificed at wk 11 for the same measurements 
as the 2 wk time point. 
 
Determination of Muscle Protein Synthesis.  
Protein synthesis was measured in skeletal muscle 90 minutes after the breakfast 
meals at 2 wk and 11 wk using the flooding dose method (11). A 100% enriched L-[2H5]-
phenylalanine solution (150mmol/L; Cambridge Isotopes, Andover, MA) was 
administrated at 150 µmol/100 g body weight and injected via tail vein (1 mL/100g body 
weight) 80 minutes after completion of the meals. 10 min later (90 minutes post meal) 
animals were killed by decapitation and hind limbs quickly removed and immersed in an 
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ice-water mixture. Gastrocnemius, plantaris, and soleus muscles were removed from 
cooled hind limbs, frozen in liquid N2 and stored at –80°C. 
Frozen muscle tissue was powdered in liquid nitrogen, and protein was 
precipitated with cold (4°C) perchloric acid (30 g/L, 1mL per 50 mg muscle tissue). The 
resulting supernatant and protein pellet were prepared for analysis by gas chromatography 
mass spectroscopy as described previously (12, 13).  The enrichment of L-[2H5]-
phenylalanine in the muscle hydrolysate was measured by GC-MS using a 6890N GC and 
a 5973N mass detector (Agilent Technologies Santa Clara, CA). Samples were run under 
electron impact ionization and in splitless mode, and phenylethylamine ions at mass-to-
charge ratio (m/z) 106 (m + 2) and 109 (m + 5) were monitored for enrichment.  
The muscle supernatant was used for determination of intracellular free 
phenylalanine enrichment.  Free amino acids were purified by ion exchange resin solid 
phase extraction (SPE) using EZ:faastTM amino acid analysis sample testing kit 
(Phenomenex Inc. Torrance, CA, USA) and 2H5-phenylalanine enrichment was 
determined using a propyl chloroformate derivative with GC-MS by monitoring the ions 
at m/z 206 (m) and 211 (m+5) (14).  
Fractional rates of protein synthesis (FSR) were determined from the rate of 
incorporation of L-[2H5]-phenylalanine into total mixed muscle protein as described 
previously (15). The time from injection of the metabolic tracer until tissue cooling was 
recorded as the actual time for L-[2H5]-phenylalanine incorporation.  FSR, defined as the 
percentage of tissue protein renewed each day, were calculated according to the formula:  
FSR=(Eb x 100)/(Ea x t) where t is the time interval between injection and cooling of 
sampled tissue expressed in days and Eb and Ea are the enrichments of [2H5]Phe in 
hydrolyzed tissue protein and in muscle free amino acids, respectively. 
 
Plasma measurements.  
Plasma was obtained from trunk blood at 2 wk and 11 wk by centrifugation at 
1800 x g for 10 min at 4°C. Plasma insulin concentrations were analyzed using a 
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commercial RIA kit for rat insulin (Linco Research, MO). Plasma amino acid 
concentrations were analyzed by HPLC using a Waters 2475 Fluorescence detector (16).   
 
Phosphorylation of 4E-BP1, S6K, Akt, and Raptor.  
Muscle supernatants were subjected to protein immunoblot analysis as described 
previously (8, 17) using a rabbit polyclonal antibody to 4E-BP1 (Bethyl Labs, 
Montgomery, TX), a rabbit polyclonal S6K antibody (Bethyl Labs, Montgomery, TX), a 
rabbit polyclonal phospho-Akt antibody (Cell Signaling, Danvers, MA), a rabbit 
polyclonal Akt antibody (Cell Signaling, Danvers, MA), a rabbit polyclonal phospho-
Raptor antibody (Cell Signaling, Danvers, MA), and a rabbit polyclonal Raptor antibody 
(Bethyl Labs, Montgomery, TX).   
 
Body Composition.   
Prior to the administration of the diet treatments and 2 and 11 weeks after the diet 
treatments began, body composition was assessed using dual energy X-ray 
absorptiometry (DXA) analysis. Rats received an anesthetic by intraperitoneal injection 
of a 0.3mg/kg dexmedetomidine (commercial name Dexdomitor) for sedation during testing.  
Before testing, the DXA (Hologic QDR 4500A, software version 11.1:3) instrument was 
be calibrated as per the manufacturer's guidelines. Rats were then transferred to the DXA  
and whole body (WB) scans were performed. All scans for a given rat were be performed 
on the same day and analyzed by the same research technician. 
 
Statistical analysis.   
All data were analyzed by SPSS 15.0 software package for windows.  A 1-way 
ANOVA was performed with the treatment group as the independent variable.  When a 
significant overall effect was detected, differences among individual means were 
assessed using Fisher’s LSD post hoc test.  All data sets were tested for normal 
distribution and variance homogeneity using Levene’s test.  When variances were not 
homogeneous, means were compared using a Games-Howell test.  Correlations were 
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determined by linear regression (Pearson’s correlation).  The level of significance was set 
at P<0.05 for all statistical tests.  Values are presented as means ± SEM.   
 
Results 
This experiment compared long term feeding of isonitrogenous, isoenergetic diets 
containing wheat, soy, egg, or whey as the protein source on the potential to produce 
body composition and skeletal muscle mass differences based on postprandial MPS 
outcomes.  Animal weights between groups were the same at the beginning of the 
experiment; however after 6 days of feeding the respective diets the soy group weighed 
significantly less than the other groups and remained significantly lighter for the duration 
of the experiment (Figure 4.1).  At 23 days of feeding the wheat group was significantly 
heavier than all the other groups and remained heavier for the duration of the experiment.  
Egg and whey groups were intermediate between soy and wheat groups for the entire 
experiment and their weights did not differ. 
Gastrocnemius weights were greater in animals fed egg and whey compared to 
animals fed wheat at 2 weeks (Figure 4.2).  At 11 weeks, the gastrocnemius muscles 
were larger in animals fed egg and whey with animals fed soy having the smallest 
gastrocnemius muscles.  Animals fed whey also had significantly larger gastrocnemius 
muscles compared to animals fed wheat at 11 weeks.     
Animals fed wheat protein had significantly greater percentage of body fat than 
animals fed egg and whey at 2 weeks (Figure 4.3).  At 11 weeks these results were 
maintained with the soy group also having significantly lower body fat levels than 
animals fed wheat protein.   
Consistent with body weight, body fat, and muscle weight data, animals fed soy 
had significantly less lean body mass than animals fed wheat, egg, or whey at 2 weeks 
and 11 weeks with no differences in lean body mass between wheat, egg, and whey 
groups at either time point (Figure 4.4).   
At 2 weeks, after a breakfast meal providing ~30% of daily energy and containing 
16% of energy as protein, plasma leu increased in animals fed egg and whey proteins but 
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not in wheat and soy groups.  The greatest concentration of plasma leu occurred in 
animals fed whey and egg protein (Table 4.6).  Similar postprandial patterns of plasma 
amino acids concentrations (i.e. whey > egg > soy > wheat) were observed for isoleucine 
and valine with whey producing the highest concentrations at 90 min after the meal 
(Table 4.6).  Other plasma amino acids varied among the groups largely in proportion to 
the amino acid content of the protein source (Table 4.6).  Lysine was different between 
animals fed soy and whey, with animals fed whey having the greatest concentration of 
postprandial lysine and animals fed soy having the lowest lysine levels. Plasma 
methionine concentrations were only increased in animals fed egg with the other groups 
not being different from food deprived controls (Table 4.6).  Plasma threonine was only 
increased by feeding whey with the other groups being no different from baseline.  At 11 
weeks this meal feeding and measurements were repeated with very similar results 
(Table 4.7).  No essential amino acid was significantly below baseline post-prandially at 
2 or 11 weeks.   
Postprandial MPS was significantly greater in animals fed egg and whey than 
animals fed wheat and soy (Figure 4.5) at both the 2 and 11 week time points with no 
significant difference between the egg and whey groups.  This was consistent with the 
post-prandial phosphorylation of the mTOR signaling targets 4E-BP1 (Figure 4.6A) and 
S6K (Figure 4.6B) at 2 weeks.  Phosphorylation of S6K increased after egg and whey 
meals but not wheat and soy with peak values obtained in the whey protein group.  
Feeding increased 4E-BP1 phosphorylation in all groups with egg and whey greater than 
wheat or soy.   
 Akt activation was determined by phosphorylation of Akt at Ser473.  Post-
prandial Akt phosphorylation was significantly greater in animals fed soy compared to all 
other groups and food deprived controls at 2 weeks (Figure 4.7A).   
Phosphorylation of Raptor at Ser792 is a surrogate marker for AMPK activity and 
represents inhibition of mTOR (18, 19). Similar to Akt activity, post-prandial Raptor 
phosphorylation was significantly increased in animals fed soy compared to all other 
groups and food deprived controls at 2 weeks (Figure 4.7B).  
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Post-prandial insulin concentrations were not different between any groups or 
different from baseline at 2 weeks (data not shown).  At 11 weeks however, animals fed 
wheat had significantly greater post-prandial insulin increases at 90 minutes after feeding 
than animals fed egg and whey (Figure 4.8).  Animals fed egg and whey exhibited a 
reduction in insulin.  Soy insulin concentrations were unchanged 90 minutes after feeding 
and not different from any other group.  
  
Discussion 
 This experiment examined the potential of long term meal feeding of 
isonitrogenous, isoenergetic meals that contained different protein sources to alter muscle 
weight and body composition in adult rats.  The major finding of this work was that 
meals containing different proteins that are considered nutritionally adequate can produce 
differential effects on MPS and ultimately different muscle weights in relation to the leu 
content of the protein.  Previous research has demonstrated that MPS and translation 
initiation responds in a dose dependent manner to administration of free leu (20).  We 
recently demonstrated that a similar effect could be achieved using whole proteins 
(wheat, soy, egg, and whey) as a part of complete meals.  That study showed that meals 
containing 47 mg or 54 mg leu from wheat and soy respectively were unable to increase 
plasma leu or MPS in adult rats, while isonitrogenous meals containing 60 mg or 74 mg 
of leu from egg or whey proteins, respectively, increased plasma leu and MPS. These 
data suggested that a narrow and highly responsive threshold exists for the relationship of 
plasma leu serving as a trigger for initiation of MPS.  This experiment extends these 
findings by demonstrating that the post prandial MPS responses to meals containing 
sufficient leu to reach this threshold are maintained for at least 11 wks and these meal 
responses produce differences in muscle mass and body composition.  To our knowledge, 
no previous studies have demonstrated the leu thresholds at meals is important to adult 
muscle mass and body composition.   
The differences in gastrocnemius muscle weights were consistent with post-
prandial MPS and translation initiation factors.  Animals with the largest gastrocnemius 
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muscles had greater rates of postprandial MPS and increased mTOR signaling.  These 
metabolic responses were associated with increases in post-prandial plasma leu and the 
leu content of the respective diets.   Animals consuming the small meals containing egg 
and whey proteins with greater leu density received sufficient dietary leu to reach the 
threshold required to increase plasma leu and trigger metabolic responses.  The mTOR 
targets S6K and 4E-BP1 were both correlated with MPS (r=0.482 and r=0.452, P<0.05) 
at 2 weeks.  Corresponding to this, MPS increased only in animals fed egg and whey.  
Likewise, plasma leu correlated with post-prandial increases in MPS at 2 (r=0.589, 
P<0.01) and 11 weeks (r=0.693, P<0.01).  These short term post-meal anabolic responses 
produced greater gastrocnemius muscle weights based on the leu content of the meals 
which were correlated with muscle weights at 2 (r=0.451, P<0.01) and 11 weeks 
(r=0.400, P=0.01).  Not surprisingly, the postprandial MPS changes were correlated with 
gastrocnemius weights at 11 weeks (r=0.471, P<0.01).  This demonstrates that short term 
rises in postprandial leu are not only crucial for increasing MPS, but for long term 
optimization of muscle mass.   
In addition to muscle weights, lean body mass and body fat related to the protein 
quality of the meals.  Leu content of the diet as well as post-prandial plasma leu, mTOR 
signaling, and MPS were associated with differences in lean body mass and body fat.  
Post-prandial MPS was correlated with lean body mass at 2 (r=0.551, P<0.001) and 11 
weeks (r=0.491, P<0.01).  Furthermore, lean body mass was also correlated with 
increases in plasma leu at 11 weeks (r=0.425, P<0.01) with a trend for significance at 2 
weeks (r=0.322, P=0.08).  In contrast, plasma leu was negatively correlated with body fat 
at 2 weeks (r=-0.417, P<0.05) and 11 weeks (r=-0.542, P<0.01).  These data support the 
hypothesis that increases in post-prandial plasma leu and MPS are critical for maintaining 
optimal LBM.  Additionally, these data suggest that increasing MPS may positively 
impact body fat.  These findings are consistent with the report by She et al. who 
demonstrated that chronic elevations in protein turnover inhibited diet induced obesity in 
a BCAT knockout model (21).  It appears that increasing plasma leu and MPS increases 
energy expenditure and positively influences body composition. She et al (21) suggested 
 63 
 
that protein turnover was a futile cycle that may explain the increased thermogenesis 
associated with higher protein diets.    
Consistent with the findings in Chapter 3, this study also found that soy protein 
increased Raptor and Akt phosphorylation but failed to stimulate S6K or 4E-BP1 
phosphorylation. Although the leu content of the breakfast & lunch meals containing soy 
do not reach the threshold required to increase plasma leu and MPS, this is compounded 
by the isoflavones content of soy, which has been shown previously to increase AMPK 
activity leading to inhibition of mTOR signaling (22).  Increased phosphorylation of 
Raptor may explain why increased Akt activity in animals fed soy is unable to increase 
mTOR signaling. Further, S6K is known to phosphorylate IRS-1 to provide feedback 
regulation of insulin signaling (23). In the absence of downstream S6k activation, the 
elevated Akt phosphorylation in the soy group may reflect dysregulation of normal 
feedback from S6K.  Interestingly, both Akt and Raptor phosphorylation were negatively 
correlated with lean body mass (r=-0.733 and r=-0.410, P<0.05).  This is consistent with 
the soy animals having the lowest bodyweights, lean body mass, and gastrocnemius 
weights.  It is likely that reduced anabolic signaling from low leu coupled with the effects 
of soy isoflavones may account for the reduced mass of animals fed soy.  Furthermore, 
activation of AMPK may at least partially explain why animals fed soy had lower 
percentage of bodyfat compared to animals fed wheat as both groups failed to increase 
plasma leu and MPS after the breakfast meal as activation of AMPK by soy protein has 
been shown to inhibit fat gain in mice (24).     
Insulin concentrations, while not different between any group and food deprived 
controls at 2 weeks, did show interesting differences at 11 weeks.  Only animals fed 
wheat had increased levels of plasma insulin at 90 minutes post-prandial while levels of 
egg and whey dropped by 88 and 149 pmol/L respectively with soy remaining unchanged 
from food-deprived levels.  A possible explanation for these differences could be that the 
90 minute post-prandial measurement does not represent the peak of insulin response, but 
rather could be a point at which insulin levels are falling.  This may suggest that animals 
fed wheat had impaired clearance of insulin or prolonged duration of insulin release with 
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better clearance or shorter duration release of insulin in animals fed egg and whey.  Soy 
was not different from baseline food deprived controls which we have observed our prior 
experiment and may be related to the isoflavones content of the soy preventing increases 
insulin concentrations (25).  These data suggest that feeding different isonitrogenous diets 
with different protein sources may potentially differentially affect insulin and glucose 
metabolism.   
This study supports the hypothesis that protein distribution at individual meals is 
an important factor for evaluation of adult protein needs (26, 27). Current protein 
requirements establish a total daily intake but provide no guidance about distribution 
throughout the day. The current study was designed to include 2 protein sources (wheat 
and soy) that would not reach the leu threshold at the breakfast and lunch meals to 
increase plasma leu and MPS and only likely receive one postprandial increase in plasma 
leu and MPS per day at the dinner meal.  In contrast to that, this study also included 2 
protein sources (egg and whey) that would contain sufficient leu at every meal to increase 
plasma leu and MPS.  This experiment demonstrates that increases in plasma (or 
intracellular) leu after meals serve as a nutrient signal for regulation of MPS (28, 29) and 
multiple stimulations per day are superior to a single response for optimizing body 
composition and muscle mass. The leu content and distribution of meals is important to 
regulation of MPS and these findings highlight that postprandial and that these meal 
responses are critical for body composition and muscle mass outcomes.  
 The unique regulatory role of leu may in part explain the inconsistencies in 
comparison of optimal needs for leu compared with current measures of minimum 
protein requirements for nitrogen balance or indispensible amino acid oxidation (IAAO) 
measurements. These standard measurements for protein requirement interpret 
postprandial increases in plasma amino acids as inefficient and excessive protein intake. 
While increased amino acid oxidation may reflect reduced efficiency of nitrogen 
retention of dietary protein and may provide an accurate representation of minimum 
requirements for an EAA such as lysine with no known metabolic signaling or regulatory 
roles, the extrapolation that protein intakes above the minimum amount for short-term 
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nitrogen balance are physiologically meaningless is not consistent with the regulatory 
role of leu in MPS.  Further support for this postulation is demonstrated by the close 
association of changes in plasma leu with rates of MPS and leu oxidation (9, 30). 
 
Conclusions 
The current study demonstrates the relationship of the meal content of leu to 
postprandial increases in plasma leu and MPS and demonstrates that these short term 
postprandial responses relate to long term body composition and muscle mass outcomes. 
These findings support the hypothesis that meal content and distribution of dietary 
protein and leu is important to adult protein utilization and highlights the ineffectiveness 
of current measures of protein quality for assessment of optimal muscle health. 
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Tables and Figures 
 
Table 4.1  Composition of animal diets 
Component Wheat Diet Soy Diet Egg Diet Whey Diet 
  g/kg   
Vital Wheat Gluten1 190.2 0.0 0.0 0.0 
Soy Protein Isolate2 0.0 185.3 0.0 0.0 
Egg White Solids3 0.0 0.0 195.6 0.0 
Whey Protein Isolate4 0.0 0.0 0.0 188.8 
L-Lysine5 10.1 0.0 0.0 0.0 
Cornstarch 316.7 331.7 321.4 328.2 
Maltodextrin 134.1 134.1 134.1 134.1 
Sucrose 101.5 101.5 101.5 101.5 
Soybean Oil 140.9 140.9 140.9 140.9 
Cellulose (Fiber) 53.7 53.7 53.7 53.7 
Mineral Mix6 37.6 37.6 37.6 37.6 
Vitamin Mix6 10.7 10.7 10.7 10.7 
Choline Bitautrate 2.7 2.7 2.7 2.7 
Biotin7 (mg/kg) 0.0 0.0 16.0 0.0 
1Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  83.4% protein, 7.6% 
carbohydrate, 9% other. 
2Soy Protein Isolate provided by Archer Daniels Midland Company, Decatur, IL.  91.6% protein, 1.4% 
carbohydrate, 7% other.  
3Egg White Solids purchased from Harlan-Teklad, Madison, WI.  87.8% Protein, 4.5% carbohydrate, 7.7% 
other. 
4Whey Protein Isolate provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate, 6.3% other. 
5Vital Wheat Gluten supplemented with 6.3g L-lysine/100g protein to match Whey Protein Isolate.   
6Mineral and Vitamin supplements (31) from Harlen-Teklad, Madison, WI. 
7Egg White Solids supplemented with 16.0 mg biotin/kg diet. 
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Table 4.2  Comparison of test diet amino acid compositions with NRC requirements1,2 
Amino Acid  Wheat Diet Soy Diet Egg Diet Whey Diet NRC 
Requirement 
   g/kg diet    
Phenyalanine/Tyrosine  11.5 17.0 16.8 10.7 1.9 
Histidine  3.1 4.2 3.9 3.4 0.8 
Isoleucine  5.1 8.1 9.0 10.5 3.1 
Leucine  11.5 13.6 14.9 18.5 1.8 
Lysine  15.4 10.7 11.0 15.4 1.1 
Methionine/Cysteine  6.5 4.4 13.9 7.6 2.3 
Threonine  4.4 6.5 7.6 10.9 1.8 
Tryptophan  2.2 2.0 2.7 2.7 0.5 
Valine  7.6 8.0 11.5 10.2 2.3 
1Table 2-2 from Nutrient Requirements of Laboratory Animals Fourth Revised Edition (32). 
2Values calculated for 300 g rat at maintenance. 
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Table 4.3  Amino acid compositions of protein sources 
Amino Acid Vital Wheat Gluten1 
Soy Protein 
Isolate2 
Egg White 
Solids3 
Whey Protein 
Isolate4 
  g/100g Protein   
Alanine 3.1 4.0 6.1 4.9 
Arginine 4.7 7.5 5.8 2.4 
Aspartate 4.0 11.5 10.3 10.6 
Cysteine 1.9 1.3 4.4 2.5 
Glutamate/Glutamine 31.7 19.2 13.1 16.9 
Glycine 3.8 4.1 3.5 1.8 
Histidine 1.8 2.5 2.3 2.0 
Isoleucine 3.0 4.8 5.3 6.2 
Leucine 6.8 8.0 8.8 10.9 
Lysine5 2.8 (+6.3) 6.3 6.5 9.1 
Methionine 1.9 1.3 3.8 2.0 
Phenylalanine 4.4 5.2 5.9 3.3 
Proline 9.4 5.2 3.8 5.6 
Serine 3.9 5.4 6.9 4.7 
Threonine 2.6 3.8 4.5 6.4 
Tryptophan 1.3 1.2 1.6 1.7 
Tyrosine 2.4 4.8 4.0 3.0 
Valine 4.5 4.7 6.8 6.0 
1Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  83.4% protein,  
7.6% carbohydrate, 9% other. 
2Soy Protein Isolate provided by Archer Daniels Midland Company, Decatur, IL.  91.6%  
protein, 1.4% carbohydrate, 7% other.  
3Egg White Solids purchased from Harlan-Teklad, Madison, WI.  87.8% Protein, 4.5% carbohydrate, 7.7% 
other. 
4Whey Protein provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate, 6.3% other. 
5Vital Wheat Gluten supplemented with 6.3g L-lysine/100g protein to match Whey Protein Isolate.   
 
 
 
 
 69 
 
Table 4.4  Protein distribution 
  Meal Breakfast  Lunch  Dinner  Total intake 
 
Diet Group  Protein intake (g)   
 
Wheat1       0.68   0.68   1.02     2.38 
 
Soy2       0.68   0.68   1.02     2.38 
 
Egg3       0.68   0.68   1.02     2.38 
 
Whey4       0.68   0.68   1.02     2.38 
1Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  83.4% protein,   
7.6% carbohydrate, 9% other. 
2Soy Protein Isolate provided by Archer Daniels Midland Company, Decatur, IL.  91.6%  
protein, 1.4% carbohydrate, 7% other.  
3Egg White Solids purchased from Harlan-Teklad, Madison, WI.  87.8% Protein, 4.5% carbohydrate, 7.7% 
other. 
4Whey Protein provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate,  
6.3% other. 
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Table 4.5  Leucine distribution  
  Meal Breakfast  Lunch  Dinner  Total intake 
 
Diet Group  Leucine intake (mg)   
 
Wheat1         46    46     69     161 
 
Soy2         54    54     76     184 
 
Egg3         60    60     90     210 
 
Whey4         74    74   111     259 
1Vital Wheat Gluten purchased from Honeyville Grain, Honeyville, UT.  83.4% protein,  
7.6% carbohydrate, 9% other. 
2Soy Protein Isolate provided by Archer Daniels Midland Company, Decatur, IL.  91.6%  
protein, 1.4% carbohydrate, 7% other.  
3Egg White Solids purchased from Harlan-Teklad, Madison, WI.  87.8% Protein, 4.5% carbohydrate, 7.7% 
other. 
4Whey Protein provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate,  
6.3% other. 
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Table 4.6  Postprandial Plasma amino acid concentrations at 2 weeks1 
 Baseline2   Wheat     Soy       Egg     Whey  
 
  µmol/L    
Leucine  91 ± 4.4b  78 ± 8.1b  78 ± 7.6b  130 ± 18.5ab  146 ± 28.4a  
 
Isoleucine  
 
74 ± 6.5b  
 
65 ± 4.3b  
 
74 ± 7.1b  
 
117 ± 15.0ab  
 
121 ± 24.0a  
 
Valine  
 
130 ± 3.4b  
 
97 ± 10.2bc  
 
118 ± 12.1b  
 
251 ± 32.9a  
 
182 ± 49.0ab  
      
 
 
∑ BCAA  
 
 
295 ± 12.0b  
 
 
245 ± 16.3c  
 
 
270 ± 26.5bc  
 
 
498 ± 66.3a  
 
 
457 ± 96.9a  
 
 
     
Lysine  543 ± 15.3ab  549 ± 79.9ab  435 ± 62.1b  492 ± 64.6ab  626 ± 46.2a  
 
Methionine  
 
53 ± 2.6ab  
 
41 ± 4.8bc  
 
38 ± 2.1bc  
 
83 ± 12.0a  
 
60 ± 19.4ab  
 
Threonine  
 
389 ± 54.2b  
 
452 ± 17.5ab  
 
518 ± 67.0ab  
 
537 ± 73.2ab  
 
860 ± 209.2a  
1Values expressed as means ± SEM, n=5-8.  Labeled means without a common letter differ (P<0.05).  
212 hr food-deprived control.  
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Table 4.7  Plasma amino acid concentrations at 11 weeks1 
          Wheat             Soy             Egg            Whey   
 FD2 Fed FD Fed FD Fed FD Fed  
          
Leucine 84 ± 5.9bc 69 ± 3.8bc 78 ± 4.4bc 78 ± 3.7bc 77 ± 3.8bc 135 ± 2.7a 86 ± 5.4 143 ± 7.8a  
Isoleucine 53 ± 4.7bc 51 ± 2.4c 57 ± 3.2bc 57 ± 2.7bc 53 ± 2.6bc 89 ± 4.5a 52 ± 3.3c 89 ± 6.1a  
Valine 118 ± 4.7cd 112 ± 11.4cd 111 ± 6.6cd 130 ± 3.8c 119 ± 6.1cd 239 ± 10.2a 125 ± 5.6cd 182 ± 10.5b  
          
∑ BCAA 255 ± 14.0bc 232 ± 11.8c 247 ± 14.1bc 265 ± 9.5bc 250 ± 12.0bc 462 ± 21.0a 263 ± 14.0bc 413 ± 23.7a  
          
Lysine 493 ± 29.2b 594 ± 48.3a 452 ± 26.9bc 438 ± 27.4bc 448 ± 24.1bc 443 ± 13.8bc 476 ± 30.7bc 540 ± 43ab  
Methionine 45 ± 1.5bc 37 ± 1.0c 40 ± 3.0bc 34 ± 0.9c 39 ± 1.9c 81 ± 5.2a 45 ± 2.2bc 55 ± 2.1b  
Threonine 290 ± 12.9cd 241 ± 15.1d 284 ± 21.6cd 288 ± 15.5cd 279 ± 21.9cd 324 ± 32.2bc 374 ± 16.5b 510 ± 33.2a  
1Values expressed as means ± SEM, n=5-8.  Labeled means without a common letter differ (P<0.05).  
212 hr food-deprived control.  
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Figure 4.1  Body weights of rats fed complete meals containing wheat, soy, egg, or whey 
proteins for 11 weeks.  Data are means; n = 13-25.  Labeled means without a common 
letter differ, P<0.05. 
*Time point (day 6) at which bodyweights of animals fed soy were significantly less than 
all other groups. 
**Time point (day 23) at which bodyweights of animals fed wheat were significantly 
larger than all other groups.
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Figure 4.2  Gastrocnemius muscle weights of rats fed complete meals containing wheat, 
soy, egg, or whey proteins for (A) 2 weeks and (B) 11 weeks.  Data are means ± SEM; n 
= 8-13.  Labeled means without a common letter differ, P<0.05.   
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Figure 4.3  Bodyfat percentages of rats fed complete meals containing wheat, soy, egg, 
or whey proteins for (A) 2 weeks and (B) 11 weeks.  Data are means ± SEM; n = 8-13.  
Labeled means without a common letter differ, P<0.05.   
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Figure 4.4  Lean body masses of rats fed complete meals containing wheat, soy, egg, or 
whey proteins for (A) 2 weeks and (B) 11 weeks.  Data are means ± SEM; n = 8-13.  
Labeled means without a common letter differ, P<0.05.   
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Figure 4.5  Postprandial rates of muscle protein synthesis in rats fed complete meals 
containing wheat, soy, egg, or whey proteins for (A) 2 weeks and (B) 11 weeks.  Data are 
means ± SEM; n = 5-8.  Labeled means without a common letter differ, P<0.05.   
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Figure 4.6  Postprandial phosphorylation of (A) 4E-BP1 and (B) S6K in rats fed 
complete meals containing wheat, soy, egg, or whey proteins for 2 weeks.  Data are 
means ± SEM; n = 7-8.  Labeled means without a common letter differ, P<0.05.   
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Figure 4.7  Postprandial phosphorylation of (A) Akt and (B) Raptor in rats fed complete 
meals containing wheat, soy, egg, or whey proteins for 2 weeks.  Data are means ± SEM; 
n = 7-8.  Labeled means without a common letter differ, P<0.05.   
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Figure 4.8  Post-prandial changes in insulin concentrations at 90 minutes after a 
complete meal containing either wheat, soy, egg, or whey proteins compared to the pre-
meal baseline. Rats had consumed the individual diet treatments for 11 wk.  Data are 
means ± SEM; n = 5-8.  Labeled means without a common letter differ, P<0.05.   
 
 
 
 
 
 
 
 81 
 
Reference List  
1. Fujita S, Volpi E. Amino acids and muscle loss with aging. J Nutr. 2006 Jan;136(1 
Suppl):277S-80S.  
2. Miller SL, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging. 
2008 Aug-Sep;12(7):487-91.  
3. Pain VM, Randall DP, Garlick PJ. Protein synthesis in liver and skeletal muscle of 
mice bearing an ascites tumor. Cancer Res. 1984 Mar;44(3):1054-7.  
4. Lang CH, Frost RA, Vary TC. Regulation of muscle protein synthesis during sepsis 
and inflammation. Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E453-9.  
5. Zangarelli A, Chanseaume E, Morio B, Brugere C, Mosoni L, Rousset P, Giraudet C, 
Patrac V, Gachon P, et al. Synergistic effects of caloric restriction with maintained 
protein intake on skeletal muscle performance in 21-month-old rats: A 
mitochondria-mediated pathway. FASEB J. 2006 Dec;20(14):2439-50.  
6. Evans W. Functional and metabolic consequences of sarcopenia. J Nutr. 1997 
May;127(5 Suppl):998S-1003S.  
7. Garlick PJ. The role of leucine in the regulation of protein metabolism. J Nutr. 
2005 Jun;135(6 Suppl):1553S-6S.  
8. Anthony JC, Anthony TG, Kimball SR, Vary TC, Jefferson LS. Orally administered 
leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in 
association with increased eIF4F formation. J Nutr. 2000 Feb;130(2):139-45.  
9. Norton LE, Layman DK, Bunpo P, Anthony TG, Brana DV, Garlick PJ. The leucine 
content of a complete meal directs peak activation but not duration of skeletal 
muscle protein synthesis and mammalian target of rapamycin signaling in rats. J 
Nutr. 2009 Jun;139(6):1103-9.  
10. Layman DK, Shiue H, Sather C, Erickson DJ, Baum J. Increased dietary protein 
modifies glucose and insulin homeostasis in adult women during weight loss. J Nutr. 
2003 Feb;133(2):405-10.  
11. Garlick PJ, McNurlan MA, Preedy VR. A rapid and convenient technique for 
measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine. 
Biochem J. 1980 Nov 15;192(2):719-23.  
12. McNurlan MA, Essen P, Thorell A, Calder AG, Anderson SE, Ljungqvist O, 
Sandgren A, Grant I, Tjader I, Ballmer PE. Response of protein synthesis in human 
 82 
 
skeletal muscle to insulin: An investigation with L-[2H5]phenylalanine. Am J 
Physiol. 1994 Jul;267(1 Pt 1):E102-8.  
13. Essen P, McNurlan MA, Gamrin L, Hunter K, Calder G, Garlick PJ, Wernerman J. 
Tissue protein synthesis rates in critically ill patients. Crit Care Med. 1998 
Jan;26(1):92-100.  
14. Mohabbat T, Drew B. Simultaneous determination of 33 amino acids and 
dipeptides in spent cell culture media by gas chromatography-flame ionization 
detection following liquid and solid phase extraction. J Chromatogr B Analyt Technol 
Biomed Life Sci. 2008 Feb 1;862(1-2):86-92.  
15. Bark TH, McNurlan MA, Lang CH, Garlick PJ. Increased protein synthesis after 
acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol. 1998 
Jul;275(1 Pt 1):E118-23.  
16. Reverter M, Lundh T, Lindberg JE. Determination of free amino acids in pig 
plasma by precolumn derivatization with 6-N-aminoquinolyl-N-
hydroxysuccinimidyl carbamate and high-performance liquid chromatography. J 
Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):1-8.  
17. Anthony TG, McDaniel BJ, Knoll P, Bunpo P, Paul GL, McNurlan MA. Feeding 
meals containing soy or whey protein after exercise stimulates protein synthesis and 
translation initiation in the skeletal muscle of male rats. J Nutr. 2007 Feb;137(2):357-
62.  
18. Pruznak AM, Kazi AA, Frost RA, Vary TC, Lang CH. Activation of AMP-activated 
protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleoside 
prevents leucine-stimulated protein synthesis in rat skeletal muscle. J Nutr. 2008 
Oct;138(10):1887-94.  
19. Shaw RJ. LKB1 and AMP-activated protein kinase control of mTOR signaling 
and growth. Acta Physiol (Oxf). 2009 May;196(1):65-80.  
20. Crozier SJ, Kimball SR, Emmert SW, Anthony JC, Jefferson LS. Oral leucine 
administration stimulates protein synthesis in rat skeletal muscle. J Nutr. 2005 
Mar;135(3):376-82.  
21. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM. 
Disruption of BCATm in mice leads to increased energy expenditure associated with 
the activation of a futile protein turnover cycle. Cell Metab. 2007 Sep;6(3):181-94.  
 83 
 
22. Tzatsos A, Kandror KV. Nutrients suppress phosphatidylinositol 3-kinase/Akt 
signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 
phosphorylation. Mol Cell Biol. 2006 Jan;26(1):63-76.  
23. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, 
Allegrini PR, Kozma SC, et al. Absence of S6K1 protects against age- and diet-
induced obesity while enhancing insulin sensitivity. Nature. 2004 Sep 
9;431(7005):200-5.  
24. Jang EH, Moon JS, Ko JH, Ahn CW, Lee HH, Shin JK, Park CS, Kang JH. Novel 
black soy peptides with antiobesity effects: Activation of leptin-like signaling and 
AMP-activated protein kinase. Int J Obes (Lond). 2008 Jul;32(7):1161-70.  
25. Cederroth CR, Vinciguerra M, Gjinovci A, Kuhne F, Klein M, Cederroth M, Caille 
D, Suter M, Neumann D, et al. Dietary phytoestrogens activate AMP-activated 
protein kinase with improvement in lipid and glucose metabolism. Diabetes. 2008 
May;57(5):1176-85.  
26. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the 
prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):86-90.  
27. Layman DK. Dietary guidelines should reflect new understandings about adult 
protein needs. Nutr Metab (Lond). 2009 Mar 13;6:12.  
28. Kimball SR, Jefferson LS. Molecular mechanisms through which amino acids 
mediate signaling through the mammalian target of rapamycin. Curr Opin Clin Nutr 
Metab Care. 2004 Jan;7(1):39-44.  
29. Norton LE, Layman DK. Leucine regulates translation initiation of protein 
synthesis in skeletal muscle after exercise. J Nutr. 2006 Feb;136(2):533S-7S.  
30. Block KP, Aftring RP, Mehard WB, Buse MG. Modulation of rat skeletal muscle 
branched-chain alpha-keto acid dehydrogenase in vivo. effects of dietary protein 
and meal consumption. J Clin Invest. 1987 May;79(5):1349-58.  
31. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A 
diet. J Nutr. 1997 May;127(5 Suppl):838S-41S.  
32. Subcommittee on Laboratory Animal Nutrition, National Research Council, 
Committee on Animal Nutrition, Board on Agriculture, editors. Nutrient requirements 
of laboratory animals, fourth revised edition.  Washington, D.C.:  National Academy 
Press; 1995.  p. 13. 
 
 84 
 
CHAPTER 5:   Protein distribution affects muscle mass based on differences in 
postprandial muscle protein synthesis and plasma leucine in rats 
 
Introduction 
Current recommendations for protein intakes are expressed as a daily 
requirement.  This recommendation is based on a substrate concept for amino acid 
requirements that assumes the protein distribution throughout the day is not important so 
long as the overall amino acid needs are met.  Current research however suggests protein 
distribution does matter as changes in protein turnover in muscle are regulated on a meal-
to-meal basis largely associated with the leucine (leu) content of the meal (1-3).  We have 
demonstrated previously that the anabolic response to a meal peaks between 45-90 
minutes post-meal and returns to baseline after 3 hours.     
Data from de Castro indicate that Americans consume over 65% of their daily 
protein after 18:30 h (4).  With the average daily protein intake for elderly at 66 g/day, it 
is unlikely that they reach a threshold of protein intake necessary to stimulate MPS at 
meals prior to 18:30 (5).  It is likely then that a large number of people only consume 
sufficient protein/leu to induce an anabolic response at dinner and this response may only 
last for 3 hours.  Research from Arnal et al. also supports the importance of a meal 
protein threshold for adults (1).  Furthermore, if the anabolic response to a high protein 
meal only lasts 3 hr, then it is likely that a large portion of the day is spent in a catabolic 
state.   
In Chapter 4, we found that isonitrogenous, isocaloric diets that induce multiple 
increases in postprandial plasma leu and MPS are superior for long term body 
composition and muscle mass as compared to diets that provide fewer postprandial 
anabolic responses.  These findings suggest that optimum protein intakes for adults 
require proteins rich in leu to be provided in multiple meals throughout the day. A logical 
extrapolation is that a person may reach their daily protein recommendation, but still not 
optimize the meal responses of MPS for optimal muscle mass.  The purpose of this 
experiment was to examine whether distribution of protein and specifically leu 
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throughout the day can have an impact on MPS, body composition, and muscle mass in 
rats fed isonitrogenous, isocaloric meals from the same protein source with the same leu 
content.   
 
Materials and Methods 
Animals and diets.   
Male Sprague-Dawley rats (275 ± 10g; Harlan-Teklad) will be maintained at 24°C 
with a 12-h light:dark cycle and free access to water. The animal facilities and protocol 
were reviewed and approved by the Institutional Animal Care and Use Committee of the 
University of Illinois at Urbana-Champaign. 
 Rats were trained to consume 3 meals/d consisting of a 4 g meal consumed 
between 07:00 and 07:20 followed by free access to food from 13:00 to 14:00 and 18:00 
to 19:00 for 6 days.  Rats consumed ~18 g/d of total diet.  On day 7, rats were 
randomized into the following diet groups (n=21-25):  ED-Whey (evenly distributed 
whey protein) and UD-Whey (unevenly distributed whey protein) and food-deprived 
controls (Table 5.1 and Table 5.2).  The diets were fed at 80% of ad libitum (14 g/day) 
intake to produce changes in body composition. In order to study meal responses and 
control for between animal differences in food intake, rats were fed defined amounts at 
each meal with 4 g meals at 07:00 and 13:00 and a 6 g meal at 18:00, representing a meal 
pattern designed to mimic human eating behavior (6).  ED-Whey provided 16% of energy 
from protein at each meal, whereas UD-Whey provided 8%, 8%, and 27.5% of energy 
from protein at breakfast, lunch, and dinner, respectively. Total daily leu, protein, 
carbohydrate, and lipid intakes were the same for all groups (Table 5.3 and Table 5.4).  
The protein and leu distributions were designed to provide 3 stimulations of MPS for 
animals fed ED-Whey vs. only a single threshold stimulation at dinner for animals fed 
UD-Whey based on previous research (Chapter 3 and 4).  After 2 wk of meal feeding 
treatment diets approximately half of the rats in each treatment group were set aside for 
determination of body composition by DXA (Dual energy X-ray absorptiometry). These 
animals were then allowed to recover and continue meal feeding for the remainder of the 
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study.  The other animals that did not undergo DXA were food deprived for 12 h and then 
either sacrificed (food-deprived group) or fed their normal first meal at the 2 wk time 
point.  The meals contained approximately 37 and 74 mg leu in the UD-Whey and ED-
Whey meals respectively.   
 Either before the breakfast meal (i.e. baseline) or 90 min after consumption of the 
meal rats were killed and blood and tissues harvested.  Tissues weighed and collected 
included the gastrocnemius, soleus, and plantaris muscles, and liver.  The remaining 
animals continued to consume the diet treatments for 9 more weeks and then underwent 
DXA and sacrificed at wk 11 for the same measurements as the 2 wk time point. 
 
Determination of Muscle Protein Synthesis.  
Protein synthesis was measured in skeletal muscle 90 minutes after the breakfast 
meals at 2 wk and 11 wk using the flooding dose method (7). A 100% enriched L-[2H5]-
phenylalanine solution (150mmol/L; Cambridge Isotopes, Andover, MA) was 
administrated at 150 µmol/100 g body weight and injected via tail vein (1 mL/100g body 
weight) 80 minutes after completion of the meals. 10 min later (90 minutes post meal) 
animals were killed by decapitation and hind limbs quickly removed and immersed in an 
ice-water mixture. Gastrocnemius, plantaris, and soleus muscles were removed from 
cooled hind limbs, frozen in liquid N2 and stored at –80°C. 
 Frozen muscle tissue was powdered in liquid nitrogen, and protein was 
precipitated with cold (4°C) perchloric acid (30 g/L, 1mL per 50 mg muscle tissue). The 
resulting supernatant and protein pellet were prepared for analysis by gas chromatography 
mass spectroscopy as described previously (8, 9).  The enrichment of L-[2H5]-
phenylalanine in the muscle hydrolysate was measured by GC-MS using a 6890N GC and 
a 5973N mass detector (Agilent Technologies Santa Clara, CA). Samples were run under 
electron impact ionization and in splitless mode, and phenylethylamine ions at mass-to-
charge ratio (m/z) 106 (m + 2) and 109 (m + 5) were monitored for enrichment.  
The muscle supernatant was used for determination of intracellular free 
phenylalanine enrichment.  Free amino acids were purified by ion exchange resin solid 
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phase extraction (SPE) using EZ:faastTM amino acid analysis sample testing kit 
(Phenomenex Inc. Torrance, CA, USA) and 2H5-phenylalanine enrichment was 
determined using a propyl chloroformate derivative with GC-MS by monitoring the ions 
at m/z 206 (m) and 211 (m+5) (10).  
Fractional rates of protein synthesis (FSR) were determined from the rate of 
incorporation of L-[2H5]-phenylalanine into total mixed muscle protein as described 
previously(11). The time from injection of the metabolic tracer until tissue cooling was 
recorded as the actual time for L-[2H5]-phenylalanine incorporation.  FSR, defined as the 
percentage of tissue protein renewed each day, were calculated according to the formula:  
FSR=(Eb x 100)/(Ea x t) where t is the time interval between injection and cooling of 
sampled tissue expressed in days and Eb and Ea are the enrichments of [2H5]Phe in 
hydrolyzed tissue protein and in muscle free amino acids, respectively. 
 
Plasma measurements.  
Plasma was obtained from trunk blood by centrifugation at 1800 x g for 10 min at 
4°C. Plasma insulin concentrations were analyzed using a commercial RIA kit for rat 
insulin (Linco Research, MO). Plasma amino acid concentrations were analyzed by 
HPLC using a Waters 2475 Fluorescence detector (12).   
 
Phosphorylation of 4E-BP1, S6K, Akt, and Raptor.  
Muscle supernatants were subjected to protein immunoblot analysis as described 
previously (13, 14) using a rabbit polyclonal antibody to 4E-BP1 (Bethyl Labs, 
Montgomery, TX), and a rabbit polyclonal S6K antibody (Bethyl Labs, Montgomery, 
TX). 
 
Body Composition.   
Prior to the administration of the diet treatments and 2 and 11 weeks after the diet 
treatments began, body composition was assessed using dual energy X-ray 
absorptiometry (DXA) analysis. Rats received an anesthetic by intraperitoneal injection 
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of a 0.3mg/kg dexmedetomidine (commercial name Dexdomitor) for sedation during testing.  
Before testing, the DXA (Hologic QDR 4500A, software version 11.1:3) instrument was 
be calibrated as per the manufacturer's guidelines. Rats were then transferred to the DXA  
and whole body (WB) scans were performed. All scans for a given rat were be performed 
on the same day and analyzed by the same research technician. 
 
Statistical analysis.   
All data were analyzed by SPSS 15.0 software package for windows.  A 1-way 
ANOVA was performed with the treatment group as the independent variable.  When a 
significant overall effect was detected, differences among individual means were 
assessed using Fisher’s LSD post hoc test.  All data sets were tested for normal 
distribution and variance homogeneity using Levene’s test.  When variances were not 
homogeneous, means were compared using a Games-Howell test.  Correlations were 
determined by linear regression (Pearson’s correlation).  The level of significance was set 
at P<0.05 for all statistical tests.  All values are presented as means ± SEM. 
 
Results 
This experiment examined whether long term feeding of isonitrogenous, 
isoenergetic diets containing whey protein distributed evenly (ED-Whey) or unevenly 
(UD-Whey) could produce body composition and skeletal muscle mass differences based 
on postprandial MPS outcomes.  Animal weights were not different between treatment 
groups at the beginning of the experiment and through 59 days of feeding.  The ED-
Whey group was significantly heavier than the UD-Whey group after 59 days (Figure 
5.1).   
Gastrocnemius muscle weights were greater in animals fed ED-Whey compared 
with animals fed UD-Whey at 2 weeks (Figure 5.2) and at 11 weeks (Figure 5.2).  UD-
Whey had a trend (p=0.09) for bigger liver weights at 2 weeks compared to ED-Whey 
(Figure 5.3).  This trend became significant at 11 weeks (Figure 5.3). 
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Body fat percentage was not different between the two groups at 2 or 11 weeks 
(Figure 5.4).  Consistent with these data, lean body mass was not different between the 
two groups at either time point (data not shown). 
At 2 weeks, after a breakfast meal providing ~30% of daily energy and containing 
16% of energy as protein, plasma leu increased in animals ED-Whey but not in animals 
fed UD-Whey  (Table 5.5).  Similar postprandial patterns of plasma amino acids 
concentrations were observed for valine and isoleucine, though the difference in 
isoleucine concentrations was not significant, with whey producing the highest 
concentrations at 90 min after the meal (Table 5.5).  Other plasma amino acids varied 
among the groups largely in proportion to the amino acid content of the meal consumed 
(Table 5.5).  Lysine was greater in the ED-Whey group compared to the UD-Whey group 
and was significantly lower than baseline levels in animals fed UD-Whey.  Plasma 
methionine concentrations were not significantly different between treatment groups 
however methionine was significantly below baseline concentrations in the UD-Whey 
group (Table 5.5).  Plasma threonine was only increased in both treatment groups 
compared to food-deprived baseline control concentrations.  At 11 weeks this meal 
feeding and measurements were repeated with very similar results with animals fed ED-
Whey having significantly greater postprandial plasma concentrations of all amino acids 
measured except for methionine as the difference was not significant (Table 5.6).  At 11 
weeks, plasma concentrations of all BCAA were reduced postprandially compared to 
baseline food-deprived values (Table 5.6).  Additionally, baseline food-deprived 
concentrations were not different between ED-Whey and UD-Whey, except isoleucine 
which was greater in UD-Whey at 11 weeks (Table 5.6).    
 Post-prandial MPS after a breakfast meal was significantly greater in animals fed 
ED-Whey compared with animals fed UD-Whey (Figure 5.5) at both the 2 and 11 week 
time points.  This was consistent with the post-prandial phosphorylation of the mTOR 
signaling targets 4E-BP1 (Figure 5.6A) and S6K (Figure 5.6B) at 2 weeks.  
Phosphorylation of S6K increased after the breakfast meal in animals fed ED-Whey but 
not UD-Whey.  Feeding increased 4E-BP1 phosphorylation in both groups however, ED-
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Whey had significantly greater levels of 4E-BP1 phosphorylation compared with animals 
fed UD-Whey.   
Post-prandial insulin concentrations were not different between the treatment 
groups or different from baseline at 2 weeks (data not shown).  At 11 weeks however, 
animals fed UD-Whey had increased postprandial insulin concentrations compared with 
baseline controls whereas animals fed ED-Whey had decreased postprandial insulin 
concentrations compared with baseline controls (Figure 5.7).   
 
Discussion 
 This experiment was performed to determine if long term feeding of 
isonitrogenous, isoenergetic diets with the same leu contents but different meal 
distribution of protein and leu could impact long term body composition and muscle mass 
based on their ability to stimulate increase postprandial leu and MPS.  The major finding 
of this work is that protein and specifically leu distribution is crucial to optimizing 
muscle mass and that multiple increases in post-prandial plasma leu and MPS are 
superior to a single increase in plasma leu and MPS.  Our previous research demonstrated 
that rats fed egg and whey producing multiple increases in plasma leu and MPS had 
better body composition and muscle mass outcomes compared to animals fed wheat and 
soy which did not produce increases in MPS at small 4g meals (Chapter 4).   
 The difference in post-prandial increases in leu and MPS were consistent with the 
differences in gastrocnemius weight.  Animals fed ED-Whey had greater postprandial leu 
and MPS increases than animals fed UD-Whey after small meals.  Also closely 
associated with plasma leu and MPS were the phosphorylation of the mTOR targets 4E-
BP1 and S6K.  We hypothesize that long term daily feeding of meals producing different 
postprandial meal responses in plasma leu and MPS lead to greater tissue deposition in 
muscle over time.   
Contrary to our previous experiment, body composition and lean body mass were 
not different between the groups.  This was somewhat surprising considering the body fat 
outcomes of animals receiving multiple stimulations of MPS per day vs. animals 
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receiving less stimulation in the previous experiment.  A possible explanation was that 
the uneven distribution of protein intake shifted tissue weights from skeletal muscle to 
other lean body tissues like the gut and liver.  Indeed, animals fed UD-Whey had 
significantly bigger livers at 11 weeks than animals fed ED-Whey.  A possible 
mechanism for these differences could be that MPS is maximized well below the level of 
protein intake fed to UD-Whey animals at dinner and but that large protein meal 
stimulates greater deposition in liver compared to the moderate protein meal consumed 
by ED-Whey.  Therefore, we hypothesize that consuming enough total leu, regardless of 
distribution will optimize bodyfat, but optimization of muscle mass requires proper 
distribution of dietary protein and leu intake.   
 Also surprising was the post-prandial insulin concentrations at 11 weeks.  At 90 
minutes post meal, animals fed ED-Whey had actually decreased insulin concentrations 
below baseline by 88 pmol/L whereas animals fed UD-Whey had increased insulin 
concentrations by 86 pmol/L above baseline. This may be due to the increased 
carbohydrate content of the breakfast meal in animals fed UD-Whey compared to ED-
Whey (62% CHO vs. 54% CHO).  The increased carbohydrate content may have caused 
a greater insulin response which had not been cleared at 90 minutes post meal.   
 Current protein recommendations are daily amounts based on short term nitrogen 
balance and amino acid oxidation studies in a steady state.  Humans however, eat in 
discreet meals producing non-steady state outcomes.  de Castro et al. reported that 
Americans consume approximately ~65% of their total protein at dinner (4).  By current 
dietary guidelines, this is acceptable so long as total daily protein requirement is met.  
However, if such a large amount of protein is consumed at dinner, it is likely that the 
other meals contain insufficient protein or leu to increase plasma leu and MPS.  In the 
current study, animals consuming UD-Whey with ~70% of their total protein intake at 
dinner had smaller gastrocnemius muscles than animals fed ED-Whey.  Therefore, it may 
be possible to meet one’s daily protein requirement, but not optimize MPS and muscle 
mass.   
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Conclusions 
The current study confirms the hypothesis that protein/leu distribution are 
important and can have differential effects on postprandial leu, mTOR signaling, and 
MPS and produce differential deposition of lean tissue mass in skeletal muscle and liver.  
Protein quantity, quality, and distribution are all important factors for producing optimal 
muscle mass and current protein recommendations may be insufficient to fully 
encapsulate the postprandial meal response effects of dietary protein and leu.   
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Tables and Figures 
 
Table 5.1  Compositions of animal diets 
Component 
 
ED-Whey  
(16% Protein) 
UD-Whey  
(8% Protein) 
UD-Whey  
(27.5% Protein) 
 
 g/kg   
 
Whey Protein Isolate1     188.8       94.4      324.5 
 
Cornstarch      328.2     422.6     192.5 
 
Maltodextrin      134.1     134.1     134.1 
 
Sucrose      101.5     101.5     101.5 
 
Soybean Oil      140.9     140.9     140.9 
 
Cellulose (Fiber)        53.7       53.7       53.7 
 
Mineral Mix2        37.6       37.6       37.6 
 
Vitamin Mix2        10.7       10.7       10.7 
 
Choline Bitautrate          2.7         2.7         2.7 
1Whey Protein Isolate provided by Perham, Perham, MN.  89.9% protein, 3.8%  
carbohydrate, 6.3% other. 
2Mineral and Vitamin supplement (15) from Harlan Teklad, Madison, WI. 
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Table 5.2  Amino acid composition of Whey Protein Isolate 
Amino Acid  Whey Protein Isolate1 
  
Alanine 4.9 
Arginine 2.4 
Aspartate 10.6 
Cysteine 2.5 
Glutamate/Glutamine 16.9 
Glycine 1.8 
Histidine 2.0 
Isoleucine 6.2 
Leucine 10.9 
Lysine5 9.1 
Methionine 2.0 
Phenylalanine 3.3 
Proline 5.6 
Serine 4.7 
Threonine 6.4 
Tryptophan 1.7 
Tyrosine 3.0 
Valine 6.0 
1Whey Protein provided by Perham, Perham, MN.  89.9%  
protein, 3.8% carbohydrate, 6.3% other. 
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Table 5.3  Protein distribution 
  Meal Breakfast  Lunch  Dinner  Total intake 
 
Diet Group  Protein intake (g)   
 
ED-Whey1       0.68   0.68   1.02     2.38 
 
UD-Whey1       0.35   0.35   1.68     2.38 
1Whey Protein provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate, 6.3% other. 
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Table 5.4  Leucine distribution  
  Meal Breakfast  Lunch  Dinner  Total intake 
 
Diet Group  Leucine intake (mg)   
 
ED-Whey1         74    74   111     259 
 
UD-Whey1          38    38   184     260 
1Whey Protein provided by Perham, Perham, MN.  89.9% protein, 3.8% carbohydrate, 6.3% other. 
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Table 5.5  Postprandial Plasma amino acid concentrations at 2 weeks1 
 Baseline2   UD-Whey  ED-Whey  
 
  µmol/L  
Leucine  91 ± 4.4b  78 ± 6.4b  146 ± 28.4a  
 
Isoleucine  
 
74 ± 6.5a  
 
72 ± 7.3a  
 
121 ± 24.0a  
 
Valine  
 
130 ± 3.4a  
 
94 ± 5.0b  
 
182 ± 49.0a  
    
 
 
∑ BCAA  
 
 
295 ± 12.0a  
 
 
233 ± 17.4b  
 
 
457 ± 96.9a  
 
 
   
Lysine  543 ± 15.3a  420 ± 27.4b  626 ± 46.2a  
 
Methionine  
 
53 ± 2.6a  
 
41 ± 3.1b  
 
60 ± 19.4ab  
 
Threonine  
 
389 ± 54.2b  
 
546 ± 41.1a  
 
860 ± 209.2a  
1Values expressed as means ± SEM, n=5-8.  Labeled means without a common letter differ (P<0.05).  
212 hr food-deprived control.  
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Table 5.6  Plasma amino acid concentrations at 11 weeks1 
                                    UD-Whey                   ED-Whey  
    FD2    Fed     FD2             Fed 
     
Leucine 97 ± 6.8b 75 ± 3.7c 86 ± 5.4bc 143 ± 7.8a 
Isoleucine 68 ± 4.9b 53 ± 2.6c 52 ± 3.3c 89 ± 6.1a 
Valine 141 ± 8.5bc 99 ± 2.7d 125 ± 5.6cd 182 ± 10.5b 
     
∑ BCAA 307 ± 19.9b 227 ± 8.5c 263 ± 14.0bc 413 ± 23.7a 
     
Lysine 528 ± 39.5bc 428 ± 25.3c 476 ± 30.7bc 540 ± 43ab 
Methionine 48 ± 2.0b 41 ± 1.5bc 45 ± 2.2bc 55 ± 2.1b 
Threonine 382 ± 23.5b 322 ± 16.8bc 374 ± 16.5b 510 ± 33.2a 
1Values expressed as means ± SEM, n=5-8.  Labeled means without a common letter differ (P<0.05).  
212 hr food-deprived control.  
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Figure 5.1  Body weights of rats fed diets with unevenly distributed (UD-Whey) or 
evenly distributed (ED-Whey) whey protein for 11 weeks.  Data are means; n = 13-25.  
Labeled means without a common letter differ, P<0.05.   
*Time point (day 59) at which bodyweights of animals were significantly different. 
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Figure 5.2  Gastrocnemius muscle weights of rats fed diets with unevenly distributed 
(UD-Whey) or evenly distributed (ED-Whey) whey protein for (A) 2 weeks and (B) 11 
weeks.  Data are means ± SEM; n = 8-13.  Labeled means without a common letter differ, 
P<0.05.   
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Figure 5.3  Liver weights of rats fed diets with unevenly distributed (UD-Whey) or 
evenly distributed (ED-Whey) whey protein for (A) 2 weeks and (B) 11 weeks.  Data are 
means ± SEM; n = 8-12.  Labeled means without a common letter differ, P<0.05.   
a 
a 
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Figure 5.4  Bodyfat percentages of rats fed diets with unevenly distributed (UD-Whey) 
or evenly distributed (ED-Whey) whey protein for (A) 2 weeks and (B) 11 weeks.  Data 
are means ± SEM; n = 8-13.  Labeled means without a common letter differ, P<0.05.   
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Figure 5.5  Postprandial rates of muscle protein synthesis in rats fed diets with unevenly 
distributed (UD-Whey) or evenly distributed (ED-Whey) whey protein for (A) 2 weeks 
and (B) 11 weeks.  Data are means ± SEM; n = 5-8.  Labeled means without a common 
letter differ, P<0.05.   
 104 
 
 
 
 
Figure 5.6  Postprandial phosphorylation of (A) 4E-BP1 and (B) S6K in rats fed diets 
with unevenly distributed (UD-Whey) or evenly distributed (ED-Whey) whey protein.  
Data are means ± SEM; n = 7-8.  Labeled means without a common letter differ, P<0.05.   
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Figure 5.7  Changes in insulin concentrations from baseline in rats fed diets with 
unevenly distributed (UD-Whey) or evenly distributed (ED-Whey) whey protein for 11 
weeks at 90 minutes post meal.  Data are means ± SEM; n = 5-8.  Labeled means without 
a common letter differ, P<0.05.   
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CHAPTER 6:  Summary, conclusions, and speculations 
 
 Current recommendations for protein quantity and quality are based on preventing 
deficiencies in limiting amino acids and are assessed with measurements focused on 
optimizing efficiency of protein intake such as nitrogen balance, DAAO, and IAAO.  
These methods interpret increases in plasma amino acids as inefficient utilization because 
of increased amino acid oxidation.  These methods view amino acids only as substrates 
for protein synthesis and fail to account for metabolic actions of amino acids such as leu 
on mTOR signaling and MPS.  The overall goal of this research was to determine if 
feeding different protein sources which met limiting amino acids requirements based on 
current standards for protein quality could produce differences in mTOR signaling, MPS, 
body composition, and muscle mass based on their leu content.  This dissertation 
provides a fundamentally new concept for protein quantity and quality based on 
optimizing protein synthesis in skeletal muscle and the leu content of proteins. This new 
approach is applicable defining protein needs for adult health and maintaining muscle 
mass and body composition.    
 The first objective of this dissertation (Chapter 2) was to determine the role leu 
plays in complete meals by 1) characterizing the time course of MPS response to a meal 
and the associated changes in plasma leu, mTOR signaling, and insulin and 2) 
determining peak activation of MPS and mTOR signaling in response to complete meals 
containing isonitrogenous protein sources with different leu contents.  To test these 
parameters we fed test meals that were balanced for protein, carbohydrates, fat and fiber 
but contained 10, 20, or 30% of total energy from wheat or whey proteins (6.8 and 10.9% 
leu), respectively.  We determined that whey increased plasma leu, mTOR signaling, and 
MPS more than wheat at all protein intakes.  The time course of MPS after meals lasted 
for 3 hours with a peak at 90 minutes; however plasma leu and mTOR signaling 
remained at a plateau for 3 hours before decreasing.  Meal leu content and the increases 
in post-prandial plasma leu were closely associated with peak activation of mTOR 
signaling and MPS.  The meal response of MPS lasted for approximately 3 hours and 
returned to baseline while plasma leu and translation initiation factors remained elevated. 
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We termed this point at the end of the post-prandial periods when MPS was not related to 
plasma leu concentration to be a “refractory response” period.     
Our second objective (Chapter 3) was to examine the potential to use leu to 
predict the quality of individual proteins to stimulate mTOR signaling and MPS at 
individual meals and determine if a threshold for increasing plasma leu and MPS exists. 
Adult rats were adapted for 2 weeks to a meal-feeding protocol with complete diets 
containing 16% protein but with different leu contents using wheat, soy, egg, or whey 
proteins (6.8, 8.0, 8.8, and 10.9% leu).  Animals fed egg and whey significantly increased 
plasma leu and MPS whereas animals fed wheat and soy and receiving the same about of 
total protein failed to stimulate MPS after the meal.  The leu content of the meals 
predicted mTOR signaling and peak MPS responses and were closely related to changes 
in plasma leu.  These findings supported the hypothesis that there is a meal leu threshold 
for increasing plasma leu.      
 The third objective (Chapter 4) was to further evaluate the findings of Chapter 3 
and to test the hypothesis that long-term meal-feeding of isonitrogenous/isocaloric diets 
with different protein sources that produced difference meal responses for MPS would 
result in different muscle mass. This study used diets with 16/54/30% of energy from 
protein/carbohydrates/lipids, respectively, using protein sources (wheat, soy, egg, whey) 
with different leu contents to produce post-prandial changes in plasma leu and MPS and 
muscle mass and body composition were evaluated after 2 and 11 weeks of meal-feeding. 
Based on the leu threshold observed in Chapter 3, the diets were designed such that 
animals fed egg and whey proteins would receive sufficient leu during each of the three 
meals to achieve three stimulations of MPS per day as opposed to animals fed wheat and 
soy proteins with lower leu contents that would achieve the leu threshold only at the 
larger dinner meal.  After 11 weeks of meal-feeding, gastrocnemius muscle weight, lean 
body mass, and body composition were positively related to the leu content of the diet 
and reflected the ability of the respective diets to increase post-prandial plasma leu and 
MPS.   
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Finally, the fourth objective (Chapter 5) was to determine if long-term differences 
in distribution of dietary protein and specifically the leu content of meals could make a 
difference in body composition.  We tested this hypothesis by feeding 
isocaloric/isonitrogenous meals containing whey protein evenly distributed to achieve the 
leu thresholds at each of 3 meals (ED-Whey) daily or unevenly distributed over 3 meals 
(UD-Whey) with only the dinner meal exceeding the leu threshold.  The ED-Whey 
treatment with evenly distributed leu produced multiple stimulations of MPS throughout 
the day and larger gastrocnemius muscle weights compared to the UD-whey that only 
achieved stimulation of MPS at a single meal. While muscle mass was larger in the ED-
Whey treatment, while liver weight was greater in the UD-Whey group.  Total body 
composition was not different between the groups. These findings suggest that the ED-
Whey treatment resulted in more efficient use of dietary protein for maintaining 
functional skeletal mass while the UD-Whey group required larger visceral mass to 
manage the protein and/or nitrogen influx at the single large protein meal.                         
 This research establishes that the leu content of a meal is an important predictor of 
post-meal MPS response and ultimately impacts adult skeletal muscle mass. These 
findings raise additional questions for future research including: examining meal 
frequency to determine the optimal number of MPS stimulations that can be achieved per 
day to optimize muscle mass.  Based on data showing a refractory response to constant 
elevations in plasma leu, it is unclear when feeding another meal may produce another 
response or if the refractory response could be overcome by feeding a meal or free form 
leu or carbohydrate.  Additional questions include determining the impact of exercise on 
the meal responses or the leu threshold.  These are important questions that will require 
further examination.     
In summary, while current protein recommendations of quality and quantity are 
sufficient to establish requirements for limiting amino acids, they do not fully encapsulate 
the metabolic benefits of amino acids such as leu.  These studies demonstrated that there 
is a threshold of leu intake at a meal required to increase plasma leu and stimulate mTOR 
signaling and MPS.  Furthermore, leu content of complete meals is an important regulator 
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of MPS and produces different body composition outcomes with long term feeding of 
diets differing in leu content and distribution.   
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